{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# Projet NLP\n",
        "# Bilal Romain Safion\n",
        "# Contexte\n",
        "  \n"
      ],
      "metadata": {
        "id": "UWof-YaksfTj"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "#!pip install --upgrade numpy\n",
        "#!pip install --force-reinstall gensim"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "uBvAefSztpGS",
        "outputId": "78df3842-446a-497c-899c-f16ac6418a98"
      },
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: numpy in /usr/local/lib/python3.11/dist-packages (1.26.4)\n",
            "Collecting numpy\n",
            "  Using cached numpy-2.2.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (62 kB)\n",
            "Using cached numpy-2.2.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (16.4 MB)\n",
            "Installing collected packages: numpy\n",
            "  Attempting uninstall: numpy\n",
            "    Found existing installation: numpy 1.26.4\n",
            "    Uninstalling numpy-1.26.4:\n",
            "      Successfully uninstalled numpy-1.26.4\n",
            "\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
            "gensim 4.3.3 requires numpy<2.0,>=1.18.5, but you have numpy 2.2.4 which is incompatible.\n",
            "numba 0.60.0 requires numpy<2.1,>=1.22, but you have numpy 2.2.4 which is incompatible.\n",
            "tensorflow 2.18.0 requires numpy<2.1.0,>=1.26.0, but you have numpy 2.2.4 which is incompatible.\u001b[0m\u001b[31m\n",
            "\u001b[0mSuccessfully installed numpy-2.2.4\n",
            "Collecting gensim\n",
            "  Using cached gensim-4.3.3-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (8.1 kB)\n",
            "Collecting numpy<2.0,>=1.18.5 (from gensim)\n",
            "  Using cached numpy-1.26.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (61 kB)\n",
            "Collecting scipy<1.14.0,>=1.7.0 (from gensim)\n",
            "  Using cached scipy-1.13.1-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (60 kB)\n",
            "Collecting smart-open>=1.8.1 (from gensim)\n",
            "  Downloading smart_open-7.1.0-py3-none-any.whl.metadata (24 kB)\n",
            "Collecting wrapt (from smart-open>=1.8.1->gensim)\n",
            "  Downloading wrapt-1.17.2-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (6.4 kB)\n",
            "Using cached gensim-4.3.3-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (26.7 MB)\n",
            "Using cached numpy-1.26.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (18.3 MB)\n",
            "Using cached scipy-1.13.1-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (38.6 MB)\n",
            "Downloading smart_open-7.1.0-py3-none-any.whl (61 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m61.7/61.7 kB\u001b[0m \u001b[31m2.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading wrapt-1.17.2-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl (83 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m83.2/83.2 kB\u001b[0m \u001b[31m6.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: wrapt, numpy, smart-open, scipy, gensim\n",
            "  Attempting uninstall: wrapt\n",
            "    Found existing installation: wrapt 1.17.2\n",
            "    Uninstalling wrapt-1.17.2:\n",
            "      Successfully uninstalled wrapt-1.17.2\n",
            "  Attempting uninstall: numpy\n",
            "    Found existing installation: numpy 2.2.4\n",
            "    Uninstalling numpy-2.2.4:\n",
            "      Successfully uninstalled numpy-2.2.4\n",
            "  Attempting uninstall: smart-open\n",
            "    Found existing installation: smart-open 7.1.0\n",
            "    Uninstalling smart-open-7.1.0:\n",
            "      Successfully uninstalled smart-open-7.1.0\n",
            "  Attempting uninstall: scipy\n",
            "    Found existing installation: scipy 1.13.1\n",
            "    Uninstalling scipy-1.13.1:\n",
            "      Successfully uninstalled scipy-1.13.1\n",
            "  Attempting uninstall: gensim\n",
            "    Found existing installation: gensim 4.3.3\n",
            "    Uninstalling gensim-4.3.3:\n",
            "      Successfully uninstalled gensim-4.3.3\n",
            "Successfully installed gensim-4.3.3 numpy-1.26.4 scipy-1.13.1 smart-open-7.1.0 wrapt-1.17.2\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "application/vnd.colab-display-data+json": {
              "pip_warning": {
                "packages": [
                  "smart_open",
                  "wrapt"
                ]
              },
              "id": "1012552f655b45bdad1086b44ebc8b62"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import re\n",
        "import string\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "#import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from nltk.stem import WordNetLemmatizer\n",
        "from nltk.corpus import wordnet\n",
        "from nltk import word_tokenize, pos_tag\n",
        "\n",
        "import gensim\n",
        "from gensim.models import Word2Vec\n",
        "\n",
        "from sklearn.feature_extraction.text import TfidfVectorizer, TfidfTransformer\n",
        "from sklearn.model_selection import train_test_split\n",
        "from sklearn.svm import SVC\n",
        "\n",
        "from sklearn.metrics import classification_report\n",
        "from sklearn.metrics import confusion_matrix"
      ],
      "metadata": {
        "id": "e_9mF-qjsj6w"
      },
      "execution_count": 1,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#Chargement des données\n",
        "df = pd.read_csv('medical_text.csv', encoding='ISO-8859-1')\n"
      ],
      "metadata": {
        "id": "aoyPwbwPsphW"
      },
      "execution_count": 2,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Restructuration du dataframe\n",
        "df.drop('Unnamed: 0',axis=1,inplace=True)\n",
        "df.rename(columns={'0':'label','a':'text'},inplace=True)\n"
      ],
      "metadata": {
        "id": "4A_lwpo8ss3t"
      },
      "execution_count": 3,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 423
        },
        "id": "jeneNpt5szJY",
        "outputId": "3cd68ace-00b2-46e0-d236-ad602917788b"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "               label                                               text\n",
              "0     Thyroid_Cancer  Thyroid surgery in  children in a single insti...\n",
              "1     Thyroid_Cancer  \" The adopted strategy was the same as that us...\n",
              "2     Thyroid_Cancer  coronary arterybypass grafting thrombosis ï¬b...\n",
              "3     Thyroid_Cancer   Solitary plasmacytoma SP of the skull is an u...\n",
              "4     Thyroid_Cancer   This study aimed to investigate serum matrix ...\n",
              "...              ...                                                ...\n",
              "7565    Colon_Cancer  we report the case of a 24yearold man who pres...\n",
              "7566    Colon_Cancer  among synchronous colorectal cancers scrcs rep...\n",
              "7567    Colon_Cancer  the heterogeneity of cancer cells is generally...\n",
              "7568    Colon_Cancer  \"adipogenesis is the process through which mes...\n",
              "7569    Colon_Cancer  the periparturient period is one of the most c...\n",
              "\n",
              "[7570 rows x 2 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2e7f03ef-57c9-4331-8e38-a07cdf925140\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>label</th>\n",
              "      <th>text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>Thyroid surgery in  children in a single insti...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>\" The adopted strategy was the same as that us...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>coronary arterybypass grafting thrombosis ï¬b...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>Solitary plasmacytoma SP of the skull is an u...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>This study aimed to investigate serum matrix ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7565</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>we report the case of a 24yearold man who pres...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7566</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>among synchronous colorectal cancers scrcs rep...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7567</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>the heterogeneity of cancer cells is generally...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7568</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>\"adipogenesis is the process through which mes...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7569</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>the periparturient period is one of the most c...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>7570 rows × 2 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2e7f03ef-57c9-4331-8e38-a07cdf925140')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-2e7f03ef-57c9-4331-8e38-a07cdf925140 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-2e7f03ef-57c9-4331-8e38-a07cdf925140');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-3aed0dda-e290-4458-a99e-8cc283088331\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-3aed0dda-e290-4458-a99e-8cc283088331')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-3aed0dda-e290-4458-a99e-8cc283088331 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_ec0982f6-1cc9-4cf6-bae0-a5589943f574\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_ec0982f6-1cc9-4cf6-bae0-a5589943f574 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 7570,\n  \"fields\": [\n    {\n      \"column\": \"label\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Thyroid_Cancer\",\n          \"Colon_Cancer\",\n          \"Lung_Cancer\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 996,\n        \"samples\": [\n          \"\\\"The normalized results are expressed as the relative mRNA level. The comparison between pre-/post-treatment groups was performed by modified paired T-test using the limma package. Fluorescence in situ hybridization (FISH) Samples were tested for ALK rearrangements by FISH (Vysis ALK Break Apart FISH Probe Kit) as previously described30. Gene expression analysis RNA from cell lines and controls was prepared labeled and hybridized to Illumina HT-12 array. For analysis the sample probe profile data in the GeneSpring export format was transformed to log-2 scale and normalized using quantile method by applying beadarray package31 in BioConductor 2.11. Four duplicated samples were averaged to reduce the total sample size to 9 across three groups. The comparison between drug sensitive and drug resistant groups was performed using limma package. The significantly changed probes were identified by moderated t statistics. The p-values from moderated t-tests were adjusted by Benjamini and Hochberg's method to control false discovery rate. The microarray data reported in this  have been deposited in NCBI's Gene Expression Omnibus (GEO) database www.ncbi.nlm.nih.gov/geo (Accession no. GSE49508 URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49508). Xenograft studies Nude mice (nu/nu; Harlan Laboratories) were used for in vivo studies and were cared for in accordance with guidelines approved by the Memorial Sloan-Kettering Cancer Center Institutional Animal Care and Use Committee and Research Animal Resource Center. 8 week old female mice were injected subcutaneously with 5 million H3122 cells together with matrigel. Once tumors reached an average volume of 100 mm3 mice were randomized to the different treatment cohorts. For the experiment in Supplementary Fig. 1f mice were randomized to receive either crizotinib alone MAb391 alone crizotinib + MAb391 or vehicle control (n = 6 for vehicle alone crizotinib and crizotinib + MAb391. n = 5 for MAb391 only). Crizotinib was administered at 50 mg kg?1 p.o. daily \\u0097 5 days. MAb391 was administered at 1 mg i.p. every 3 days. For the experiment in Fig. 6b mice were randomized to receive crizotinib alone (50 mg kg?1 p.o. daily \\u0097 5 days) LDK-378 alone (50 mg kg?1 p.o. daily \\u0097 5 days) or vehicle control (n = 5 for Crizotinib and LDK-378 n = 4 for vehicle control). Mice were observed daily throughout the treatment period for signs of morbidity/mortality. Tumors were measured twice weekly using calipers and volume was calculated using the formula: length \\u0097 width2 \\u0097 0.52. Body weight was also assessed twice weekly. P values were determined with the Wilcoxon Rank Sum test. EML4-ALK (E13;A20) transgenic mice Genetically engineered mice harboring the EML4-ALK E13;A20 fusion variant has been previously reported13. Three month old mice from both genders were used in the described studies. All animal treatment studies were reviewed and approved by the IACUC at the Dana-Farber Cancer Institute. Tumor Biopsy Samples All patient tumor biopsy samples were obtained under Institutional Review Board (IRB) approved protocols (Vanderbilt University IRB# 050644 Memorial Sloan-Kettering Cancer Center IRB #10-136 University Hospital of Cologne IRB #06037 Peter MacCallum Cancer Center IRB#08/71). Written informed consent was obtained from all patients. All samples were deidentified and protected health information was reviewed according to the Health Insurance Portability and Accountability Act (HIPAA) guidelines. For the index patient's tumor clinical genotyping was performed using the SNaPshot platform as previously described32. Immunohistochemistry Tumors were pathologically identified and classified according to WHO guidelines. Briefly 3 ?m thick sections of FFPE tumors were deparaffinized. For pIGF-1R staining antigen retrieval was performed by boiling the section in citrate buffer at pH 6 for 25 minutes. For IRS-1 staining no pretreatment was necessary. Primary antibodies were used as follows: pIGF-1R (pY1161) (Ab39398 1:100 pH 6 Abcam Inc.) IRS-1 (Ab40777 1:100 Abcam Inc.). Corresponding secondary antibodies and detection kits were used (Enhancer: post antibody blocking for Bright Vision plus; Immuno Logic c-DPVB blocking and Polymer: Poly-HRP-GAM/R/R IgG; Immuno Logic c-DPVB999HRP BrightVision+ cat #DPVB999HRP ImmunoLogic Duiven The Netherlands www.immunologic.nl) and stained on an automated stainer (LabVision Autostainer 480S Thermo Scientific). Staining intensities were individually evaluated by 3 independent observers. Supplementary Material 1 Acknowledgements This work was supported by the VICC Cancer Center Core grant (P30-CA68485) a career development award from the Vanderbilt Specialized Program of Research Excellence in Lung Cancer grant (CA90949) NCI grants R01CA121210 and P01CA129243 and by the Joyce Family Foundation. CML was additionally supported by an NIH K12 training grant (K12 CA9060625) an ASCO Young Investigator Award a Uniting Against Lung Cancer grant and a Damon Runyon Clinical Investigator Award. CML was the Carol and Jim O'Hare chief fellow from 7/1/2011 through 6/30/2012. LCH and RB were supported by the Deutsche Forschungsgemeinschaft (SFB 832 Tumormicromilieu) and the German Cancer Aid (CIO K\\u00b6ln Bonn).\\\"\",\n          \"\\\"confidence. If you choose not to take part in this survey it will not affect the care you receive from the NHS in any way. Please do not write your name and address anywhere on the questionnaire as this information is not required. No information you give in this questionnaire will be shared in a way that allows you to be identified. How to complete the survey and how long it will take. The questionnaire is short and will take 5\\u009310?min to complete. Please try to answer every question. Please return your questionnaire even if you have not answered every question. If English is not your first language or if you if you have difficulty understanding the questions then please ask a relative or carer to help you complete the questionnaire. Questions or help? If you have any questions please contact your local lung clinical nurse specialist team. Please select one answer to each question by placing a in the appropriate box. There is space at the end of the survey for you to write any comments. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. Abdel-Rahman M Stockton D Rachet B Hakulinen T Coleman MP 2009 What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable Br J Cancer 101 (Suppl 2 S115 S124 19956155 Aveling EL Martin G Jimnez Garc\\u00ada S Martin L Herbert G Armstrong N Dixon-Woods M Woolhouse I 2012 Reciprocal peer review for quality improvement: an ethnographic case study of the Improving Lung Cancer Outcomes Project BMJ Qual Saf 21 1034 1041 Beckett P Woolhouse I Stanley R Peake MD 2012 Exploring variations in lung cancer care across the UK-the \\u0098story so far' for the National Lung Cancer Audit Clin Med 12 14 18 22372213 Department of Health2012National Cancer Patients' Experience Survey Programme 2012/13. England. Health And Social Care Information Centre2012National Lung Cancer Audit Report. Institute for Healthcare Improvement2003The Breakthrough Series: IHI's Collaborative Model for Achieving Breakthrough Improvement. Boston. Khakwani A Rich AL Powell HA Tata LJ Stanley RA Baldwin DR Duffy JP Hubbard RB 2013 Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit Br J Cancer 109 (8 2058 2065 24052044 Kwon S Florence M Grigas P Horton M Horvath K Johnson M Jurkovich G Klamp W Peterson K Quigley T Raum W Rogers T Thirlby R Farrokhi E Flum D 2012 Creating a learning healthcare system in surgery: Washington State's Surgical Care and Outcomes Assessment Program (SCOAP) at 5 years Surgery 151 146 152 22129638 National Institute for Health and Care Excellence 2011 The Diagnosis And Treatment Of Lung Cancer (Update Of Nice Clinical Guideline 24) Clinical guidelines CG121 London UK Pronovost P Needham D Berenholtz S Sinopoli D Chu H Cosgrove S Sexton B Hyzy R Welsh R Roth G Bander J Kepros J Goeschel C 2006 An intervention to decrease catheter-related bloodstream infections in the ICU N Engl J Med 355 2725 2732 17192537 Roberts CM Stone RA Buckingham RJ Pursey NA Lowe D Potter JM 2012 A randomized trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project: three-year evaluation J Eval Clin Pract 18 (3 599 605 21332611 Walters S Maringe C Coleman MP Peake MD Butler J Young N Bergstr\\u00b6m S Hanna L Jakobsen E K\\u00b6lbeck K Sundstr\\u00b8m S Engholm G Gavin A Gjerstorff ML Hatcher J Johannesen TB Linklater KM McGahan CE Steward J Tracey E Turner D Richards MA Rachet B ICBP Module 1 Working Group 2013 Lung cancer survival and stage at diagnosis in Australia Canada Denmark Norway Sweden and the UK: a population-based study 2004-2007 Thorax 68 551 564 23399908 Wise J 2010 Health atlas shows large variations in care in England BMJ 341 c6809 c6809  Study timelines.  Consort diagram disposal of eligible trusts including screening randomisation and follow-up.  Run chart showing the waiting times from the multidisciplinary team meeting to the first treatment for 10 consecutive small-cell lung cancer patients following the implementation of the quality improvement plan at one trust in the intervention group.  Mean change in national lung cancer audit metrics from baseline (2009) to 2011. P=0.055 active treatment\\u0094intervention vs controls. Intervention n=31 trusts control n=47 trusts and non-intervention (control and non-participants combined) n=66 trusts. Abbreviations: CNS clinical nurse specialist; MDT multidisciplinary team; SCLC small-cell lung cancer.  Total patient questionnaire scores by the multidisciplinary team in the intervention group at baseline (pre) and at the end of the study (post). A low score indicates better experience. Each symbol represents the mean score for each trust in the intervention group. The maximum possible score for the questionnaire is 11.  Quality improvement plan themes Quality improvement plan theme Number of plans Multidisciplinary team effectiveness 31 Diagnostic pathways 13 Treatment pathways 9 Access to clinical nurse specialists 8 Clinical trial recruitment 4 Patient experience 2  Baseline (2009) national lung cancer audit indicators   Control ( n =47) Intervention ( n =31) Excluded ( n =67) P -value   Mean (%) s.e.m. Mean (%) s.e.m. Mean (%) s.e.m. Control vs intervention vs non-participant control vs intervention Case ascertainment 158.1 38.6 122.0 7.2 107.4 3.6 0.220 0.455 Discussed at the MDT meeting 95.2 0.7 93.7 1.7 90.9 1.9 0.155 0.370 Histological confirmation rate 75.7 1.2 76.4 1.8 78.4 1.6 0.409 0.739 Active treatment 59.5 1.2 55.9 2.2 59.5 1.5 0.305 0.131 Surgery (all cases) 13.4 0.6 13.0 0.8 14.2 0.7 0.469 0.648 SCLC (chemo) 65.1 2.2 66.5 3.9 63.3 2.7 0.746 0.733 Seen by CNS 70.3 3.8 76.6 3.2 58.3 4.2 0.007 0.243 CNS present diagnosis 44.0 3.8 49.4 5.4 38.7 3.8 0.237 0.403 Abbreviations: CNS=clinical nurse specialist; MDT=mulitdisciplinary team; SCLC=small-cell lung cancer. Data are shown as mean and s.e. proportion of patients. BMC Cancer BMC Cancer BMC Cancer 1471-2407 BioMed Central 24386906 3893473 1471-2407-14-3 10.1186/1471-2407-14-3 Study Protocol Study protocol of a randomized controlled trial comparing Mindfulness-Based Stress Reduction with treatment as usual in reducing psychological distress in patients with lung cancer and their partners: the MILON study Schellekens Melanie PJ 1 Melanie.Schellekensradboudumc.nl van den Hurk Desiree GM 2 Desiree.vandenHurkradboudumc.nl Prins Judith B 3 Judith.Prinsradboudumc.nl Molema Johan 2 Johan.Molemaradboudumc.nl Donders A Rogier T 4 Rogier.Dondersradboudumc.nl Woertman Willem H 4 Willem.Woertmanradboudumc.nl van der Drift Miep A 2 Miep.vanderDriftradboudumc.nl Speckens Anne EM 1 Anne.Speckensradboudumc.nl 1Department of Psychiatry Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 2Department of Pulmonary Diseases Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 3Department of Medical Psychology Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 4Department of Epidemiology Biostatistics and Health Technology Assessment Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 2014 3 1 2014 14 3 3 28 6 2013 19 12 2013 Copyright  2014 Schellekens et al.; licensee BioMed Central Ltd. 2014 Schellekens et al.; licensee BioMed Central Ltd. This is an open access  distributed under the terms of the Creative Commons Attribution License (http://creativecommons./licenses/by/2.0) which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Background Lung cancer is the leading cause of cancer death worldwide and characterized by a poor prognosis. It has a major impact on the psychological wellbeing of patients and their partners. Recently it has been shown that Mindfulness-Based Stress Reduction (MBSR) is effective in reducing anxiety and depressive symptoms in cancer patients. The generalization of these results is limited since most participants were female patients with breast cancer. Moreover only one study examined the effectiveness of MBSR in partners of cancer patients. Therefore in the present trial we study the effectiveness of MBSR versus treatment as usual (TAU) in patients with lung cancer and their partners. Methods/Design A parallel group randomized controlled trial is conducted to compare MBSR with TAU. Lung cancer patients who have received or are still under treatment and their partners are recruited. Assessments will take place at baseline post intervention and at three-month follow-up. The primary outcome is psychological distress (i.e. anxiety and depressive symptoms). Secondary outcomes are quality of life (only for patients) caregiver appraisal (only for partners) relationship quality and spirituality. In addition cost-effectiveness ratio (only in patients) and several process variables are assessed. Discussion This trial will provide information about the clinical and cost-effectiveness of MBSR compared to TAU in patients with lung cancer and their partners. Trial registration ClinicalTrials.gov NCT01494883. Mindfulness-based stress reduction Lung cancer patients Partners Psychological distress Randomized controlled trial Background With an estimated 1.4 million deaths per year lung cancer is the leading cause of death by cancer worldwide. Even with the best available treatment five-year survival is merely 16% and about 60 to 70% of patients die within the first year after diagnosis [1]. This poor prognosis is often caused by a late diagnosis as the presentation usually occurs when the lung cancer is advanced. Patients may develop burdensome symptoms like pain dyspnoea fatigue and cough and they may undergo radical treatment including surgery chemo- and radiotherapy. Not surprisingly lung cancer has a major impact on the psychological wellbeing of patients and their family. Akechi and colleagues [2] showed that 19% of patients with advanced lung cancer meets the criteria of psychiatric disorders especially depressive and adjustment disorders. Of patients who had been successfully treated for lung cancer 15% met the criteria for a minor or major depressive disorder [3]. The prevalence rate of depressive and anxiety symptoms among lung cancer patients ranges from 20 to 47% [4-7]. Compared to patients with other cancer diagnoses lung cancer patients report the highest rates of distress (43 to 58%) [89] resulting in a lower quality of life [10]. Family friends and especially partners of patients with lung cancer also have to deal with its psychological impact [11-14]. Partners not only provide emotional and practical support they also have to cope with their own concerns including the uncertainty regarding the course of the illness and the fear of losing their partner [15]. More than 50% of partners of lung cancer patients report negative emotional effects of caregiving [16]. Around 40% of partners of patients with advanced lung cancer report high levels of distress [17]. The relationship between patient and partner can also be affected by the cancer. It has been shown that some partners report a lower quality of their relationship after the diagnosis of lung cancer [18]. Though numerous studies examined the psychological distress of lung cancer patients and their partners [2-22] not much research is done on how to alleviate distress in these groups [23]. In addition the available studies on managing the psychosocial care needs of cancer patients and their families have focused on care at the very end of life (e.g. [24-26]). Recently studies have demonstrated that palliative care initiated early in treatment improves the quality of life and depressive symptoms of lung cancer patients [1027]. This stresses the importance of integrating psychosocial care for lung cancer patients and their partners early in the treatment rather than instigating it once life-prolonging therapies fail. In the past ten years MBSR has become a promising psychosocial intervention for cancer patients. Mindfulness is defined as intentionally paying attention to moment-by-moment experiences in a non-judgmental way [28]. MBSR is an 8-week group-based training consisting of meditation practices such as the bodyscan gentle yoga sitting and walking meditation. By repeatedly bringing attention back to the current experience participants gradually learn to disengage from dysfunctional thoughts and directly experience the emotions and bodily sensations of the present moment. MBSR aims to provide participants with the ability to step back from ruminating about the past or worrying about the future and simply allow experiences to unfold [2829]. A recent meta-analysis [30] of 13 nonrandomized studies and 9 randomized controlled trials (RCT) concluded there is positive evidence for the use of mindfulness-based interventions in reducing psychological distress in cancer patients. Among the RCT\\u0099s a reduction in symptom severity was found for both anxiety and depression corresponding to moderate pooled controlled effect sizes (Hedges\\u0099s g = 0.37 and Hedges\\u0099s g = 0.44 respectively) [30]. Though mindfulness-based interventions seem to be effective the authors note that across studies the majority of participants were women (85%) and diagnosed with breast cancer (77%). Compared to breast cancer patients patients with lung cancer are more often male older and have a poorer prognosis. Furthermore of these 22 studies only one study included the partners of the patients showing that partners also benefit from the MBSR training [31]. This is quite surprising since partners of cancer patients also report high levels of distress [32]. Aims The aim of the Mindfulness for Lung Oncology Nijmegen (MILON) study is to examine the effectiveness of MBSR compared to TAU in reducing psychological distress in patients with lung cancer and their partners. We hypothesize that patients in the MBSR group will report a lower level of psychological distress (i.e. anxiety and depressive symptoms) higher levels of quality of life quality of relationship and spirituality than those in the TAU group. Medical and societal costs will be lower in the MBSR versus TAU group. We expect partners in the MBSR group to report a lower level of psychological distress and higher levels of caregiver appraisal relationship quality and spirituality than their counterparts in the TAU group. With regard to the working mechanisms of the MBSR programme we will examine changes in mindfulness skills self-compassion rumination intrusion avoidance and adherence to MBSR. Methods/Design Study design The design of the \\u0098MILON\\u0099 study is a parallel group randomized controlled trial with an embedded process study. Participants are randomized between MBSR and TAU. The study protocol has been approved by our ethical review board (CMO Arnhem-Nijmegen) and registered under number 2011\\u0093519. Participants and procedure Patients and partners are recruited at the outpatient \\\"\",\n          \"\\\"dramatic spread of Coronavirus Disease  COVID19 has profound impacts on every continent and life Due to humantohuman transmission of COVID19 nuclear medicine staffs also cannot escape the risk of infection from workplaces Everystaff in the nuclear medicine department must prepare for and respond to COVID19 pandemic which tailored to the characteristics of our profession This  provided the guidance prepared by the Korean Society of Nuclear Medicine KSNM incooperation with the Korean Society of Infectious Disease KSID and Korean Society for HealthcareAssociated InfectionControl and Prevention KOSHIC in managing the COVID19 pandemic for the nuclear medicine department We hope that thisguidance will support every practice in nuclear medicine during this chaotic periodKeywords Coronavirus  COVID19  Nuclear medicine  Prevention and control  Practice guideline HoYoung Leedebobkrgmailcom Department of Nuclear Medicine CHA Bundang Medical CenterCHA University of Medicine Professor Pocheon Republic ofKorea Department of Nuclear Medicine Seoul National UniversityBundang Hospital Professor Seongnam Gyeonggido Republic ofKorea Department of Nuclear Medicine Samsung Medical CenterSeoul Republic of Korea Department of Nuclear Medicine Seoul National UniversityHospital Seoul Republic of Korea Department of Nuclear Medicine Chosun University HospitalGwangju Republic of Korea Department of Nuclear Medicine Korea University Guro HospitalSeoul Republic of Korea Department of Nuclear Medicine Hanyang University Guri HospitalSeoul Republic of Korea Department of Nuclear Medicine National Cancer CenterGoynag Republic of Korea Department of Nuclear Medicine Seoul Medical CenterSeoul Republic of Korea Division of Nuclear Medicine Department of RadiologyEunpyeong St Mary\\u0099s Hospital College of Medicine The CatholicUniversity of Korea Seoul Republic of Korea Department of Nuclear Medicine Soonchunhyang University SeoulHospital Bucheon Republic of Korea Department of Nuclear Medicine Inje University Haeundae PaikHospital Busan Republic of Korea Department of Nuclear Medicine Keimyung University DongsanMedical Center Daegu Republic of Korea Department of Nuclear Medicine Soonchunhyang UniversityCheonan Hospital Cheonan Republic of Korea Department of Nursing Soonchunhyang University BucheonHospital Bucheon Republic of Korea Division of Infectious Disease Department of Internal MedicineKangdong Sacred Heart Hospital Hallym UniversityChuncheon Republic of Korea Department of Nuclear Medicine Soonchunhyang UniversityBucheon Hospital Bucheon Republic of Korea Department of Nuclear Medicine Korea University Anam Hospital Korean Society of Nuclear Medicine Quality Control CommitteeSeoul Republic of KoreaBucheon Republic of Korea 0cIntroductionSince the first reports of Coronavirus Disease  COVID in Wuhan China the infection had spread worldwiderapidly and COVID19 has reached pandemic levels InSouth Korea since its outbreak in February  COVID has affected profoundly every aspect of communities Thehumantohuman transmission of COVID19 provides challenges for all healthcare facilities and healthcare providersIn the face of the COVID19 pandemic the Korean Societyof Nuclear Medicine KSNM Korean Society of InfectiousDisease KSID and Korean Society for HealthcareAssociated Infection Control and Prevention KOSHIC haveprepared the guidance for the nuclear medicine department tominimize confusion and ensure that nuclear medicine physicians and technicians continue to provide their services whileprotecting the patients and workers and preventing the transmission of the virus The Quality Control Committee ofKSNM reviewed several reports and recommendations previously published by the European Association of NuclearMedicine EANM [] Society of Nuclear Medicine andMolecular Imaging SNMMI American Society of NuclearCardiology ASNC [] International Atomic Energy AgencyIAEA and others [\\u0093] This guidance is basically in compliance with the COVID19 guidelines of the Korea Centersfor Disease Control and Prevention KCDC [\\u0093] Finallythis document was prepared in cooperation with KSID andKOSHIC KSNM emphasize that this guidance must be considered in the context of following the state and hospital infection control policies and flexibly applied according tochanges in circumstances and evidenceGeneral Principles During COVID19PandemicIn a pandemic situation such as COVID19 if necessarythe condition of the scheduled patient can be checked inadvance to adjust the examination schedule Nonurgent elective studies or therapy should be postponed in COVID19confirmed or COVID19suspectedpatients Rescheduling the studiestherapy must be donein a discussion with the referring clinicians Only urgent studies or therapy could be performed inCOVID19confirmed or COVID19suspected patientswhenever clinically appropriate The priority of studytherapy should be based on a casebycase indepth discussion between nuclear medicine physicians and referring clinicians In case of performing the urgent studiestherapy consult with the infection control offices of eachinstitution to comply with the infection control rules ofownNucl Med Mol Imaging  \\u0093 COVID19suspected patients should undergo COVID testing before performing the studiestherapy Lung ventilation scan should not be performed in anyCOVID19confirmed or COVID19suspected patients Lowdose radioiodine therapy may be considered in caseof acute hyperthyroidism patients who are unable to tolerate antithyroid medications As lowdose radioiodinetherapy lower than  GBq of I131 can be performedin an outpatient setting in South Korea COVID19infected patient can be administrated lowdoseradioiodine in the isolation room or negative pressureroom without any additional monitoring related toradioiodine therapyConsideration During the StudyTherapy Patient transportationScheduling COVID19confirmed or COVID19suspected patient as last study of the day to preventcrossinfection in the nuclear medicine department Ensure that other patients or caregivers should notaccess the nuclear medicine department to minimizethe exposure to COVID19 patient during the studytherapy Transfer the COVID19infected patient to the nuclear medicine department using negative pressuretransport bag to minimize exposure and contact todroplet COVID19 patients should wear masks at all timesof procedures If necessary add gowns gloves etc Devices and scanner management Mainly use disposable instruments or items Do notreuse disposable items such as oxygen masks nasalprongs suction tubes or suction lines The protocolfor reusable devices is as follows Cleaning After use the equipment contaminated with blood bodyfluids secretions and feces should be delivered to awashing room with care not to contaminate the surrounding environment The washing place should be separated from the spaceused for cleaning other items or other patients After immersing the contaminated equipment in a washing spacewash the product carefully to avoid splashing Wash enough to remove blood body fluids secretionsand feces from remaining 0cNucl Med Mol Imaging  \\u0093 Staff undertaking cleaning should wear KF94 or N95masks longsleeved waterproof gowns goggles or faceshields hats shoe covers or rubber boots and doublegloves outer gloves are rubber gloves Disinfection and sterilization Depending on the risk level of the device according tothe Spaulding Classification of medical equipmentdevices noncritical devices require lowlevel disinfectionsemicritical devices require highlevel disinfectionsterilization and critical devices must be sterilized Disinfectants and sterilization methods by device classification should be followed in accordance with the notificationof the Ministry of Health and Welfare   Be sure to check the disinfectant manufacturer\\u0099s recommendations The recommended disinfection process suchas dilution and application time of disinfectant and theeffective period and concentration of disinfectant arestrictly followed Laboratory and scan room management Only the minimum number of staffs should be placedin the nuclear medicine department All participatingstaffs should wear appropriate personal protectiveequipment PPE eye protection with goggles or faceshield medical protective masks N95KF94 or equivalent respirator disposable latex gloves disposablegown disposable shoe covers etc Cover the scanner couch or other equipment with aplastic cover to prevent contamination Every effort should be made to minimize theCOVID19 exposure to medical staff during injection of radiopharmaceuticalsSelect the protocol with the shortest duration of uptake time and scan time to minimize the time spentby the COVID19 patient in the departmentIn case of studies requiring an uptake phaseCOVID19 patients should be waiting in separatespace If possible COVID19 patients wait in negative pressure transport bag If negative pressuretransport bag is not available use bed or stretcherin waiting room with disposable cover Considerusing standard radiopharmaceutical dose to shortenthe procedure time After the completion of image acquisition the scanroom and patient\\u0099s space area should be disinfectedaccording to the standard protocol After image acquisition remove the plastic cover ofthe scanner and disinfect the scanner surface Remove and discard PPE adequately when leavingthe camera room or care area and immediately perform hand hygieneIn case of performing the radiolabeling of theCOVID19 patients\\u0099 blood products every processwith infectious materials openingstirringmixingdispensing COVID19 patient\\u0099s blood sampleradiolabeling etc should be done in class II biosafety cabinet according to the Biosafety Level Regulation Disinfection of laboratory with properdisinfectants  ethanol  hydrogen peroxide or  ppm sodium hypochlorite should bedone Used PPE and disposable covers are removed withcaution not to contaminate the clean area and disposed in a container for biosafety waste Employee management All employees should be trained in the preventionand management of COVID19 infection and adhereto the rules of infection prevention Considering the skill level fatigue etc of the working staff sufficient personnel are allocated to securethemPriority from exemption is given to employees withhighrisk underlying diseases such as diabetesmellitus chronic obstructive pulmonary diseaseCOPD endstage renal disease ESRD chroniccardiac disease etc or pregnant women Cleaning and environmental management General principle Personnel responsible for cleaning or disinfectionshould complete the infection preventioneducation Employees should wear PPE KF94 or N95 respirators fullbody protective clothing or aprons goggles or face shields shoe covers or rubber bootsdouble gloves outer gloves are rubber gloveswhen cleaning or disinfectingIf there are organic substances on the surface of theenvironment it cannot be properly disinfectedTherefore wipe the surface before disinfecting theenvironmentIn order to prevent the possibility of microbialspraying cleaning should be performed using acleaning solution or a mop moistened with a disinfectant rather than a cleaning method using abroom or a vacuum cleanerInstead of spraying disinfectants thoroughly cleanthe surface of the environment using a clean towelmoistened with the disinfectant or a commerciallyavailable disinfecting tissue towel 0cNucl Med Mol Imaging  \\u0093 Use cleaning tools as disposable as possible or exclusively However when the cleaning tool isreused the used cleaning tool is sterilized usingan appropriate disinfectant and then dried andstored Disinfection of a patient\\u0099s space areaIn the case of the space area used by the patientmark the place where contamination was confirmedbefore cleaning and disinfecting the surface andseal the contaminated object to prevent others frombeing exposed Ventilation before during and after cleaningdisinfection disinfection after ventilation for  hbased on  air cycles per hour Wear PPE Wipe with a cloth cloth etc wet withthe diluted disinfectant Wipe the touched wall surface and all frequently used areas and keep it for atleast  min After then wipe the surface with acloth dampened with clean water cloth etcResumption of use Consider the characteristics ofeach type of disinfectant used and the purpose of thefacility After disinfection the virus is killed but thedecision at the time of resumption of use cannot beapplied in batch due to different characteristics ofdisinfectants so it is necessary to consider the precautions for each productFor details on disinfecting methods such as surfacedisinfection and washing refer to \\u009cDisinfectionGuidelines to Prevent the Spread of COVID19 atPublic and Multipurpose Facilities 3rd edition\\u009dRefer to the method of disinfecting the patient spaceareaSelect an environmental disinfectant Select an approved or declared disinfectant by the Ministry ofEnvironment and follow the usage usage and precautions for each product Disinfectant list of the Ministry of Environmenthttpecolifemegokr Precautions when using environmentaldisinfectants Select the disinfectant after confirming informationsuch as approval from the Ministry of Environmentand Environment When using environmental sterilizers make sure tofollow the manufacturer\\u0099s recommendations suchas checking the expiration date safe usage for eachproduct and precautions and preparing the diluentaccording to the manufacturer\\u0099s instructions The disinfecting method of sprayinginjecting disinfectant is not applied to surface disinfectionbecause it causes aerosol infection increased riskof inhalation and the range of contact between thedisinfectant and the surface is insufficient so thedisinfecting effect is insufficient Disinfectant hazard information must be checkedand used carefully Do not mix different disinfectants Do not placenear flammable materials Disinfectant should beused in a wellventilated area As the disinfection effect may decrease over timedilute as much as necessary and use it immediatelyDo not store the remaining amount and discard itimmediately Laundry managementStore clean laundry in a separate space Employees handling laundry should be trained toprevent infection Employees handling contaminated laundry shouldwear PPE N95 masks or equivalent respiratory protection gowns gloves overshoes etc and performhand hygiene after removing PPE The laundry used for the patient is disposed of according to the relevant regulations see WasteManagement Act Medical Institution LaundryManagement Rules etc Thoroughly ensure that pathogens are not exposed topersonnel handling the laundry or surrounding environment during the entire process of collectingtransporting and washing laundry Waste management Waste related to COVID19 patients is managed bythe rules of hospital infectious control policySharp tools such as needles or blades are collectedin containers for impervious and nonpermanentwaste and containers should be stored in the placewhere the items are usedSimple infectious waste contaminated or possiblycontaminated with COVID19 patients\\u0099 sample isautoclaved and discarded Radioactive waste shouldbe discarded in compliance with national regulationwith caution not to contaminate the staff or areaConclusionConsidering that outbreaks of novel viruses have been periodically appearing these days nuclear medicine staffs should getused to guidance and policies for infectious disease in working 0cNucl Med Mol Imaging  \\u0093place to protect patients worker themselves and furthermorevaluable medical resources Basically this guidance can beapplied in case of any other humantohuman transmissiondisease for operating the nuclear medicine department Alsoalways bear in mind the rapid change in the situation thisguidance should be used in conjunction with the currentgovernment and local hospital policiesCompliance with Ethical StandardsConflict of InterestJiIn Bang HoYoung Lee Young Seok ChoHongyoon Choi Ari Chong Jae Sun Eo Ji Young Kim Tae SungKim HyunWoo Kwon Eun Jeong Lee Eun Seong Lee Hye LimPark Soo Bin Park Hyekyung Shim BongIl Song Ik Dong YooKyung Jae Lee Hong Jae Lee Su Ha Han Jin Seo Lee Jung Mi Parkand Sung Hoon Kim declare that they have no conflict of interestEthical Approval This work does not contain any studies with humanparticipants or animals performed by any of the authorsInformed Consent Not applicableReferences Paez D Gnanasegaran G Fanti S Bomanji J Hacker M SathekgeM et al COVID19 pandemic guidance for nuclear medicine departments Eur J Nucl Med Mol \\u0093 Skali H Murthy VL AlMallah MH Bateman TM Beanlands RBetter N et al Guidance and best practices for nuclear cardiologylaboratories during the coronavirus disease  COVID19 pandemic an information statement from ASNC and SNMMI J NuclCardiol \\u0093 httpsdoiorg101007s12350020021232 Huang HL Allie R Gnanasegaran G Bomanji J COVID19\\u0093nuclear medicine departments be prepared NuclMedCommun MossaBasha M Medverd J Linnau K Lynch JB Wener MHKicska G et al Policies and guidelines for COVID19 preparedness experiences from the University of Washington Radiology httpsdoiorg101148radiol2020201326 Zhang X Shao F Lan X Suggestions for safety and protectioncontrol in Department of Nuclear Medicine during the outbreak ofCOVID19 Eur J Nucl Med Mol \\u0093 Buscombe JR Notghi A Croasdale J Pandit M O'Brien J GrahamR et al COVID19 guidance for infection prevention and controlin nuclear medicine Nucl Med Commun \\u0093 Standard guideline for healthcareassociated infection control andprevention Korean Center for Disease Control and Prevention andKorean Society for HealthcareAssociated Infection Control andPrevention  httpcdcgokrCDCcmscontentmobile2675626_viewhtml Accessed 2nd Jun  Korean Society for HealthcareAssociated Infection Control andPrevention Korean Center for Disease Control and Preventionhttpwwwcdcgokrboardesmida20507020000bid0019actviewlist_no366579 Accessed 2nd Jun  Guidelines in response to coronavirus disease for local governmentKorea Centers of Disease Control and Prevention2020 httpswwwcdcgokrboardboardesmida20507020000bid0019actviewlist_no367279tagnPage1 Accessed 2ndJun  Disinfection guidelines to prevent the spread of COVID19 at public and multipurpose facilities Korea Centers of Disease Controland Prevention  httpswwwcdcgokrboardboardesmida20507020000bid0019 Acessed 15th Jun Publisher\\u0099s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations 0c\\\"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Analyse du jeu de données\n",
        "print(\"Taille du dataset :\", df.shape)\n",
        "print(\"\\nRépartition des classes :\\n\", df['label'].value_counts())\n",
        "print(\"\\nExemple de texte brut :\\n\", df['text'].iloc[0])\n",
        "print(\"\\nLongueur moyenne des textes (bruts) :\", df['text'].apply(len).mean())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "NQOrLbtouvso",
        "outputId": "828bf473-aa17-44e5-ea13-5f68efca2c61"
      },
      "execution_count": 7,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Taille du dataset : (7570, 2)\n",
            "\n",
            "Répartition des classes :\n",
            " label\n",
            "Thyroid_Cancer    2810\n",
            "Colon_Cancer      2580\n",
            "Lung_Cancer       2180\n",
            "Name: count, dtype: int64\n",
            "\n",
            "Exemple de texte brut :\n",
            " Thyroid surgery in  children in a single institution from Osama Ibrahim Almosallama Ali Aseerib Ahmed Alhumaida Ali S AlZahranic Saif Alsobhib Saud AlShanafeybFrom the  aDepartment of Surgery College of Medicine Qassim University Buraidah Al Qassim Saudi Arabia  bDepartment of Surgery King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia cDepartment of Medicine King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia Correspondence   Dr  Osama Ibrahim  Almosallam  Department of  Surgery  College  of  Medicine Qassim  University  PO  Box   Buraidah  Al  Qassim   Saudi  Arabia  osama_iaahotmailcom ORCID orcid0000000290367564        Citation  Almosallam OI Aseeri A Alhumaid A AlZahrani AS Alsobhi S AlShanafey S Thyroid surgery in  children  in  a  single  institution  from   Ann  Saudi  Med         Received January  Accepted May  Published August  Copyright Copyright   Annals of Saudi Medicine Saudi Arabia This is an   access  under the Creative Commons AttributionNonCommercialNoDerivatives  International License CC BYNCND The details of which can be accessed at httpcreativecommons licensesbyncnd40Funding NoneBACKGROUND Data on thyroid surgery in children are scarceOBJECTIVE Analyze outcome data on thyroid surgery in a pediatric populationDESIGN Medical record reviewSETTING Tertiary health care institutionPATIENTS AND METHODS We collected demographic and clinical data on patients  years or younger who had thyroid surgery in the period  to  Descriptive data are presentedMAIN OUTCOME MEASURES Indications for thyroidectomy thyroid pathology complications length of stay and radioactive iodine treatment and recurrencesSAMPLE SIZE RESULTS Of  patients who underwent  thyroidectomy procedures   were females and the mean age at operation was  years and   were associated with multiple endocrine neoplasia type  There was no history of radiation exposure Eightyone patients  had fine needle aspiration FNA which correlated with the final histopathology in  of cases Sixtysix patients  had malignant cancer  papillary   of  patients who had neck dissection had lymph node metastasis and   had distant metastases to the lung Procedures included total thyroidectomy  hemithyroidectomy  completion  and subtotal thyroidectomy  Twentythree  patients    developed  hypocalcemia    permanent and   had unilateral recurrent laryngeal nerve injury  permanent Patients were followed up for a mean duration of  months median  months Of  patients with thyroid cancer   received radioactive iodine and   had recurrence  Malignancy  is  the  commonest  indication  for  thyroid surgery  in  children  and  FNA  is  highly  diagnostic  Hypocalcemia  and recurrent laryngeal nerve injury are significant complications The recurrence rate in thyroid cancer is  LIMITATIONS RetrospectiveCONFLICT OF INTEREST Noneoriginal ANN SAUDI MED  JULYAUGUST WWWANNSAUDIMEDNET 0cThyroid  diseases  requiring  surgery  are  relatively uncommon in children compared to adults The prevalence  of  palpable  thyroid  nodules  in  children  ranges  from    to    Sporadic  welldifferentiated thyroid cancer is the most common endocrine malignancy in children accounting for  of pediatric cancers  in  the  prepubertal  age  group  and  up  to   of cancers in adolescents aged  year2 The most common indication for thyroid surgery in children varies among published studies but thyroidectomy for malignant conditions is rising38 Data in children throughout the  world  are  relatively  scarce  The  objective  of  this study was to analyze the clinical data and outcome of thyroid  surgery  in  a  large  series  of  children  treated  at a  single  center  at  King  Faisal  Specialist  Hospital  and Research Center KFSHRC in RiyadhPATIENT AND METHODS With the approval of the Institutional Review Board IRB at KFSHRC the medical records of all patients  years old and younger who underwent a thyroid surgery between    and    were  retrospectively  reviewed We elected to include patients up to the year  to ensure a reasonable followup period Patients for the study were identified by a search of the operating room log for all procedures involving the thyroid gland for the specified age groupDemographic  data  clinical  features  and  surgical outcomes  were  collected  Specific  data  that  were  obtained included age at operation gender family history presenting  symptoms  history  of  radiation  exposure presence of multiple endocrine neoplasia type  MEN   thyroid  function  test  presence  and  size  of  thyroid nodules by ultrasound presence of lymph nodes metastasis or distant metastasis fine needle aspiration FNA cytology  surgical  procedure  final  histopathology  and length of followup Outcomes analyzed were postoperative complications including transient or permanent hypocalcemia  transient  or  permanent  recurrent  laryngeal nerve paralysis wound infection and hematoma length of stay and radioactive iodine treatment and recurrences Thyroid procedures in this series included hemithyroidectomy  subtotal  total  and  completion  thyroidectomy Surgeries were performed by either an endocrine adult surgeon or a pediatric surgeon No intraoperative nerve monitoring was used Early in the series procedures were performed by adult endocrine surgeons but lately a combined approach was adopted where pediatric surgeons and adult endocrine surgeons collaborated in such cases  proceduresthe normal range in our laboratory regardless of symptoms Transient hypocalcemia was identified if it lasted for less than  months while permanent hypocalcemia was  considered  if  the  serum  calcium  level  remained below normal range and the patient continued on calcium  supplementation  after    months  of  the  surgery All patients with a family history of MEN  underwent genetic testing of the RET protooncogene to confirm the diagnosis All patients who underwent completion thyroidectomy  had  a  preoperative  and  postoperative vocal  cords  assessment  at  the  Otolaryngology  clinic Descriptive data were generated and comparisons were conducted using the t test for continuous data and the chisquare or Fisher exact tests for proportionsRESULTSBetween    and      patients  underwent   surgical  procedures    patients  underwent  two  procedures  for  thyroid  disease  at  our  institution  Eighty  patients  were females The mean age at operation was  years median  years range  years The most common indication for thyroidectomy was thyroid nodule which was present in   of cases Table  The mean SD size of thyroid nodules was   mm There were  cases  associated with MEN  syndromes The final pathology in two patients with MEN syndrome showed medullary thyroid cancer MTC while the remaining  patients had prophylactic procedures before development of MTC None of the patients had a history of radiation exposure Eightyone patients  FNA  which  correlated  with  the  final  histopathology  in  of cases There were three cases of toxic adenoma and one case of Graves disease which did not require FNA  The  remaining  cases  underwent  FNA  at  another institution and FNA was not repeated at our institution or they came for completion thyroidectomy with documented  pathology  for  malignancy  after  they  had  their first surgery in another hospitalThe  most  common  diagnoses  included  papillary thyroid cancer  and multinodular goiter or colloid Table  Indications for thyroidectomy in  patients IndicationNodulen  MEN  prophylaxisHyperthyroidismMultinodular goiterCompletion thyroidectomy    Hypocalcemia was defined by calcium levels below Data are number  original PEDIATRIC THYROID SURGERYANN SAUDI MED  JULYAUGUST WWWANNSAUDIMEDNET 0cnodule  Table  Surgical procedures included total thyroidectomy  hemithyroidectomy  completion  thyroidectomy    and  subtotal  thyroidectomy  Neck dissection was performed in   patients  Operative  complications  were  observed in    patients    The  most  common  complication was hypocalcemia  transient  permanent and Table  Thyroid pathology in the  patientsPathologyn  BenignNormal thyroid tissueColloid noduleCystAdenomaThyroiditisGraves diseaseThyroid cancerPapillaryFollicularMedullaryHurthleAnaplasticTotalData are number              Table  Benign and malignant lesions in  patientsBenignn37Malignantn66 P value  Age meanyearsGender malefemalePresence of noduleHypocalcemiaRecurrent laryngeal nerve palsyBleedinghematomaWound infectionTracheal injuryOverall complicationsMean length of stay daysMEN recurrent laryngeal nerve palsy  transient  permanent all were unilateral Table  Of  patients with malignant lesions   had lymph node metastasis and  patients  had distant metastases to the lung  None  of  the  patients  developed  postoperative bleeding wound infection or tracheal injury Patients were followed up for a mean of  months median   range    months  radioactive  iodine  treatment  was  delivered  to    patients    with  malignant  lesions    patients    had  recurrences   were  local  recurrences  and    were  local  and  distant recurrences to the lung Three cases received radioactive iodine RAI before and after recurrence One case was low risk before recurrence so did not receive RAI until after recurrence One case had medullary thyroid cancer  so  did  not  receive  RAI  In  the  remaining  five cases  there was no clear data whether those patients received RAI before or only after a recurrence All local recurrences  underwent  resection  except  for  one  patient who was lost follow up There was no mortality in this study DISCUSSIONThe most common indication for thyroidectomy in this series was thyroid nodule which correlates with previously published reports in the pediatric population35 Children with thyroid nodules have an estimated fourfold  higher  risk  of  developing  thyroid  cancer  compared to adults910 The high incidence of malignancy in this series suggests children with a thyroid nodule should be carefully evaluatedFNA is a valuablemethod for preoperative evaluation of thyroid nodules However there are limitations on  the  routine  use  of  FNA  in  children  including  the need  for  sedation  sampling  errors  and  the  limited availability  of  experienced  cytopathologists11  Many previous studies reported high sensitivity and specificity of FNA in evaluating thyroid nodule in children1114 which correlate with our findingsOur data showed lymph node metastasis in  of  thyroid  cancer  cases  which  supports  the  notion that  children  with  thyroid  cancer  frequently  present with more extensive disease than adults Lymphnode involvement  at  diagnosis  is  seen  in    to    of children  compared  with    to    of  adults  with differentiated thyroid cancer1523 Because our hospital is the largest referral center in Saudi Arabia especially for oncology cases this may explain the large number of lymph node and distant metastasis In this cohortThe  most  common  complication  reported  after thyroidectomy in children is hypoparathyroidism with an incidence ranging between  to  which original PEDIATRIC THYROID SURGERYANN SAUDI MED  JULYAUGUST WWWANNSAUDIMEDNET 0ccorresponds with our results of  which are reported as hypocalcemia in Table    One study found that total thyroidectomy central and bilateral neck dissection Graves disease and malignancy were  risk  factors  for  hypocalcemia  after  thyroid  surgery3 In this cohort postoperative hypocalcemia was noted more in malignant cases but it failed to reach statistical significance Moreover there was no significant difference between benign and malignant cases in  terms  of  mean  age  gender  distribution  recurrent laryngeal nerve injury or overall complications a finding that was reported previously26 Multiple studies in recent years have found an inverse relationship between surgeon volume and complication  rates2728  but  similar  data  in  the  pediatric population is lacking One study found that highvolume  endocrine  surgeons  have  better  outcomes  and shorter lengths of stay and lower costs after thyroidectomy and parathyroidectomy in children compared to pediatric surgeons general surgeons or otolaryngologists29  Scheumann  and  colleagues  also  concluded that a collaborative approach between pediatric and endocrine surgeons would have better outcomes This has led other authors to suggest that a combined approach with endocrine and pediatric surgeons in addition to pediatric endocrinologists may optimize the care of children with surgical thyroid disease given the low number of pediatric patients4 Our data do not allow for comparisons of different approaches given the late adoption of the combined approach The  recurrence  rate  for  thyroid  cancer  in  children after  thyroidectomy  has  varied  widely  in  reported studies  ranging  from    to    while  it  was   in  this  cohort  Only  a  few  studies  explored  the predictors  of  recurrence  Lymph  node  involvement multiple nodules male gender younger age histologic subtype and advanced tumor stage were risk factors associated with recurrence17233033 In  this  study    of  patients  with  malignant  lesions received RAI Although there are conflicting data regarding  the  indications  of  postoperative  RAI  treatment in lowrisk patients the current recommendation is that lowrisk patients can be treated without RAI3436There are some limitations to this study The retrospective nature may affect the validity and quality of the data The small number of cases in some categories did not enable us to compare groups and explore predictors relative to these factors On the other hand this study adds to the scarce data on thyroid surgery in pediatric age group Malignancy is the commonest indication  for  thyroid  surgery  in  children  and  FNA  is highly  diagnostic  Hypocalcemia  and  recurrent  laryngeal nerve injury are significant complications Cancerrelated  death  is  extremely  rare  but  recurrence  is  not uncommon and a significant number of patients with malignant cases received RAI treatmentoriginal PEDIATRIC THYROID SURGERYANN SAUDI MED  JULYAUGUST WWWANNSAUDIMEDNET 0cREFERENCES  Trowbridge  FL  Matovinovic  J  McLaren GD Nichaman MZ Iodine and goiter in children Pediatrics  Ries LAG Melbert D Krapcho M Stinchcomb  DG  Howlader  N  Horner  MJ  et  al SEER  Cancer  Statistics  Review   Bethesda  National  Cancer  Institute   Based  on  November    SEER  data  submission Chen Y[h] Masiakos PT Gaz RD Hodin RA Parangi S Randolph GW et al Pediatric thyroidectomy in a high volume thyroid surgery center Risk factors for postoperative hypocalcemia J Pediatr Surg  Aug5081316   Wood  JH  Partrick  DA  Barham  HP  Bensard DD Travers HS Bruny JL et al Pediatric thyroidectomy  a  collaborative  surgical  approach J Pediatr Surg  May4658238  Scholz S Smith JR Chaignaud B Shamberger  RC  Huang  SA  Thyroid  surgery  at Childrens Hospital Boston a 35year singleinstitution  experience  J  Pediatr  Surg   Mar46343742   Josefson  J  Zimmerman  D  Thyroid  nodules and cancers in children Pediatr Endocrinol Rev  Sep611423 Hameed R Zacharin MR  Changing face of paediatric and adolescent thyroid cancer J Paediatr Child Health   LugoVicente  H  Ortiz  VN  Irizarry  H Camps  JI  PagÃ¡n  V  Pediatric  thyroid  nodules management in the era of fine needle aspirationJ Pediatr Surg  Mussa A De Andrea M Motta M Mormile A  Palestini  N  Corrias  A  Predictors  of  Malignancy in Children with Thyroid Nodules J Pediatr  Oct167488692 Amirazodi E Propst EJ Chung CT Parra DA  Wasserman  JD  Pediatric  thyroid  FNA biopsy  Outcomes  and  impact  on  management over  years at a tertiary care center Cancer Cytopathol    Partyka  KL  Huang  EC2  Cramer  HM Chen  S  Wu  HH  Histologic  and  clinical followup  of  thyroid  fineneedle  aspirates in  pediatric  patients  Cancer  Cytopathol  Sinha CK Decoppi P Pierro A Brain C Hindmarsh P Butler G et al Thyroid Surgery in Children Clinical Outcomes Eur J Pediatr Surg  Oct2554259 Kundel A Thompson GB Richards ML Qiu LX Cai Y Schwenk FW et al Pediatric Endocrine Surgery A 20Year Experience at the  Mayo  Clinic  J  Clin  Endocrinol  Metab February   Jiang W Newbury RO Newfield RS Pediatric  thyroid  surgery  and  management  of thyroid  nodulesan  institutional  experience features  and over a 10year period Int J Pediatr Endocrinol  Burke JF Sippel RS Chen H Evolution of Pediatric Thyroid Surgery at a Tertiary Medical Center Surg Res     AlQahtani  KH  Tunio  MA  Al  Asiri  M Aljohani NJ Bayoumi Y Riaz K et al Clinicopathological treatment outcomes  of  differentiated  thyroid  cancer in  Saudi  children  and  adults  J  Otolaryngol Head Neck Surg  Nov  Kluijfhout WP van Beek DJ Verrijn Stuart  AA  Lodewijk  L  Valk  GD  Van  der  Zee DC  et  al  Postoperative  Complications After  Prophylactic  Thyroidectomy  for  Very Young  Patients  With  Multiple  Endocrine Neoplasia  Type    Medicine  Baltimore 20159429e1108  Raval MV Browne M Chin AC Zimmerman D Angelos P Reynolds M Total thyroidectomy  for  benign  disease  in  the  pediatric patientfeasible  and  safe  J  Pediatr  Surg  Stavrakis AI Ituarte PH Ko CY Yeh MW Surgeon volume as a predictor of outcomes in  inpatient  and  outpatient  endocrine  surgery Surgery   Sosa JA Bowman HM Tielsch JM Powe NR  Gordon  TA  Udelsman  R  The  importance of surgeon experience for clinical and economic  outcomes  from  thyroidectomy Ann Surg   Tuggle CT  Roman SA Wang TS Boudourakis  L  Thomas  D  Udelsman  R  et  al Pediatric  endocrine  surgery  Who  is  operating  on  our  children  Surgery   Dec144686977  Park  S  Jeong  JS  Ryu  HR  Lee  C  Park JH Kang S et al Differentiated Thyroid Carcinoma of Children and Adolescents27Year Experience  in  the  Yonsei  University  Health System J Korean Med Sci   Palmer BA Zarroug AE Poley RN Kollars  JP  Moir  CR  Papillary  thyroid  carcinoma in children risk factors and complications  of  disease  recurrence  J  Pediatr  Surg  Wada N Sugino K Mimura T Nagahama M  Kitagawa  W  Shibuya  H  et  al  Pediatric differentiated  thyroid  carcinoma  in  stage  I risk  factor  analysis  for  disease  free  survival BMC Cancer    D Danese Gardini A Farsetti A Sciacchitano  S  Andreoli  M  Pontecorvi  A  Thyroid carcinoma in children and adolescents Eur J Pediatr   Astl  J  Chovanec  M  Lukes  P  Katra  R Dvorakova M Vlcek P et al Thyroid carcinoma surgery in children and adolescents   years experience surgery of pediatric thyroid lymph  node  metastases carcinoma  Int  J  Pediatr  Otorhinolaryngol   Chaukar  DA  Rangarajan  V  Nair  N Nadkarni  MS  Pai  PS  Dcruz  AK  et  al  Pediatric  thyroid  cancer  J  Surg  Oncol     Dzodic  R  Buta  M  Markovic  I  Gavrilo D Matovic M Milovanovic Z et al Surgical management  of  welldifferentiated  thyroid carcinoma  in  children  and  adolescents   years of experience of a single institution in Serbia Endocr J   Scheumann  GF  Gimm  O  Wegener G  Hundeshagen  H  Dralle  H  Prognostic significance  and  surgical  management  of locoregional in papillary thyroid cancer World J Surg   Shi RL Qu N Yang SW Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model Onco Targets Ther    Zimmerman D Hay ID Gough IR Goellner JR Ryan JJ Grant CS et al Papillary thyroid carcinoma in children and adults longterm  followup  of    patients  conservatively treated at one institution during three decades Surgery   Collini  P  Mattavelli  F  Pellegrinelli  A Barisella M Ferrari A Massimino M Papillary carcinoma of the thyroid gland of childhood and adolescence Morphologic subtypes biologic behavior and prognosis a clinicopathologic study of  sporadic cases treated at a single institution during a 30year period Am J Surg Pathol   BorsonChazot  Causeret  S  Lifante  JC Augros M Berger N Peix JL Predictive factors for recurrence from a series of  children and  adolescents  with  differentiated  thyroid cancer World J Surg   Baumgarten HD Bauer AJ Isaza A MostoufiMoab S Kazahaya K Adzick NS Surgical management of pediatric thyroid disease Complication  rates  after  thyroidectomy  at the Childrens Hospital of Philadelphia highvolume Pediatric Thyroid Center Journal of pediatric  surgery    Oct   Kurzawinski TR De Coppi P Thyroidectomy in Children InPediatric Surgery  pp  Springer Berlin Heidelberg  Francis  G  Waguespack  SG  Bauer  AJ Angelog P Benvenga S et al Management Guidelines  for  Children  with  Thyroid  Nodules  and  Differentiated  Thyroid  Cancer  The American  Thyroid  Association  Guidelines Task Force on Pediatric Thyroid Cancer THYROID Volume  Number  original PEDIATRIC THYROID SURGERYANN SAUDI MED  JULYAUGUST WWWANNSAUDIMEDNET 0c'\n",
            "\n",
            "Longueur moyenne des textes (bruts) : 24973.722324966973\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(f\"Nombre total de documents : {len(df)}\")\n",
        "print(f\"Répartition des classes :\\n{df['label'].value_counts()}\")\n",
        "print(f\"Longueur moyenne des textes : {df['text'].apply(len).mean()} caractères\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Fyo6XdBpz0Zv",
        "outputId": "cb9552ff-d3d8-4193-9cbe-da83c823af37"
      },
      "execution_count": 29,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Nombre total de documents : 7570\n",
            "Répartition des classes :\n",
            "label\n",
            "Thyroid_Cancer    2810\n",
            "Colon_Cancer      2580\n",
            "Lung_Cancer       2180\n",
            "Name: count, dtype: int64\n",
            "Longueur moyenne des textes : 24973.722324966973 caractères\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Distribution des classes\n",
        "plt.figure(figsize=(10, 5))\n",
        "sns.countplot(data=df, x='label')\n",
        "plt.title(\"Répartition des classes\")\n",
        "plt.show()\n",
        "\n",
        "# Nuage de mots fréquents\n",
        "from wordcloud import WordCloud\n",
        "text_all = \" \".join(df['text'])\n",
        "wordcloud = WordCloud(width=800, height=400).generate(text_all)\n",
        "plt.imshow(wordcloud, interpolation='bilinear')\n",
        "plt.axis('off')\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 756
        },
        "id": "ovHCZKM0z3-H",
        "outputId": "c13a0cf2-6198-4afa-aa29-9f8f88ab0904"
      },
      "execution_count": 30,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x500 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def get_wordnet_pos(treebank_tag):\n",
        "    if treebank_tag.startswith('J'):\n",
        "        return wordnet.ADJ\n",
        "    elif treebank_tag.startswith('V'):\n",
        "        return wordnet.VERB\n",
        "    elif treebank_tag.startswith('N'):\n",
        "        return wordnet.NOUN\n",
        "    elif treebank_tag.startswith('R'):\n",
        "        return wordnet.ADV\n",
        "    return ''"
      ],
      "metadata": {
        "id": "5Nk6FpXSs3vj"
      },
      "execution_count": 5,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def preprocess_text(text):\n",
        "    text = re.sub(\"\\[.+\\]\",\"\",text)\n",
        "\n",
        "    tokens = word_tokenize(text)\n",
        "    lemmatizer = WordNetLemmatizer()\n",
        "\n",
        "    data_processed = []\n",
        "\n",
        "    for i, word in enumerate(tokens):\n",
        "        pos = get_wordnet_pos(pos_tag([word])[0][1])\n",
        "        if pos != '':\n",
        "            data_processed.append(lemmatizer.lemmatize(word, pos))\n",
        "        else:\n",
        "            data_processed.append(word)\n",
        "\n",
        "    data_processed = [word.lower() for word in data_processed if word.isalpha()]\n",
        "    data_processed = [word for word in data_processed if not word in stopwords.words('english')]\n",
        "\n",
        "    return data_processed"
      ],
      "metadata": {
        "id": "rkWIfBlxs55D"
      },
      "execution_count": 8,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Chargement des données processed\n",
        "df_processed = pd.read_excel('medical_text_processed.xlsx')"
      ],
      "metadata": {
        "id": "d90AFnjas93F"
      },
      "execution_count": 9,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df = df_processed.copy()"
      ],
      "metadata": {
        "id": "pSS-dRzrs_lc"
      },
      "execution_count": 10,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_processed"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 423
        },
        "id": "R3cw4rPutA0a",
        "outputId": "0bf7379b-da3f-43d8-8caf-0197bf08361b"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "               label                                               text  \\\n",
              "0     Thyroid_Cancer  Thyroid surgery in  children in a single insti...   \n",
              "1     Thyroid_Cancer  \" The adopted strategy was the same as that us...   \n",
              "2     Thyroid_Cancer  coronary arterybypass grafting thrombosis ï¬b...   \n",
              "3     Thyroid_Cancer   Solitary plasmacytoma SP of the skull is an u...   \n",
              "4     Thyroid_Cancer   This study aimed to investigate serum matrix ...   \n",
              "...              ...                                                ...   \n",
              "7565    Colon_Cancer  we report the case of a 24yearold man who pres...   \n",
              "7566    Colon_Cancer  among synchronous colorectal cancers scrcs rep...   \n",
              "7567    Colon_Cancer  the heterogeneity of cancer cells is generally...   \n",
              "7568    Colon_Cancer  \"adipogenesis is the process through which mes...   \n",
              "7569    Colon_Cancer  the periparturient period is one of the most c...   \n",
              "\n",
              "                                         processed_text  \n",
              "0     ['thyroid', 'surgery', 'child', 'single', 'ins...  \n",
              "1     ['adopt', 'strategy', 'use', 'prior', 'year', ...  \n",
              "2     ['coronary', 'arterybypass', 'graft', 'thrombo...  \n",
              "3     ['solitary', 'plasmacytoma', 'sp', 'skull', 'u...  \n",
              "4     ['study', 'aim', 'investigate', 'serum', 'matr...  \n",
              "...                                                 ...  \n",
              "7565  ['report', 'case', 'man', 'present', 'chief', ...  \n",
              "7566  ['among', 'synchronous', 'colorectal', 'cancer...  \n",
              "7567  ['heterogeneity', 'cancer', 'cell', 'generally...  \n",
              "7568  ['adipogenesis', 'process', 'mesenchymalstem',...  \n",
              "7569  ['periparturient', 'period', 'one', 'challenge...  \n",
              "\n",
              "[7570 rows x 3 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-1052ca20-a4a4-4843-8e6a-5a9a418f3686\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>label</th>\n",
              "      <th>text</th>\n",
              "      <th>processed_text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>Thyroid surgery in  children in a single insti...</td>\n",
              "      <td>['thyroid', 'surgery', 'child', 'single', 'ins...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>\" The adopted strategy was the same as that us...</td>\n",
              "      <td>['adopt', 'strategy', 'use', 'prior', 'year', ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>coronary arterybypass grafting thrombosis ï¬b...</td>\n",
              "      <td>['coronary', 'arterybypass', 'graft', 'thrombo...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>Solitary plasmacytoma SP of the skull is an u...</td>\n",
              "      <td>['solitary', 'plasmacytoma', 'sp', 'skull', 'u...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Thyroid_Cancer</td>\n",
              "      <td>This study aimed to investigate serum matrix ...</td>\n",
              "      <td>['study', 'aim', 'investigate', 'serum', 'matr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7565</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>we report the case of a 24yearold man who pres...</td>\n",
              "      <td>['report', 'case', 'man', 'present', 'chief', ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7566</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>among synchronous colorectal cancers scrcs rep...</td>\n",
              "      <td>['among', 'synchronous', 'colorectal', 'cancer...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7567</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>the heterogeneity of cancer cells is generally...</td>\n",
              "      <td>['heterogeneity', 'cancer', 'cell', 'generally...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7568</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>\"adipogenesis is the process through which mes...</td>\n",
              "      <td>['adipogenesis', 'process', 'mesenchymalstem',...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7569</th>\n",
              "      <td>Colon_Cancer</td>\n",
              "      <td>the periparturient period is one of the most c...</td>\n",
              "      <td>['periparturient', 'period', 'one', 'challenge...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>7570 rows × 3 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-1052ca20-a4a4-4843-8e6a-5a9a418f3686')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-1052ca20-a4a4-4843-8e6a-5a9a418f3686 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-1052ca20-a4a4-4843-8e6a-5a9a418f3686');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-3b07300f-dabd-4973-9298-ddee6396639b\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-3b07300f-dabd-4973-9298-ddee6396639b')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-3b07300f-dabd-4973-9298-ddee6396639b button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_cf705147-4ab0-4a47-afba-3011f74a9357\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df_processed')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_cf705147-4ab0-4a47-afba-3011f74a9357 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df_processed');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_processed",
              "summary": "{\n  \"name\": \"df_processed\",\n  \"rows\": 7570,\n  \"fields\": [\n    {\n      \"column\": \"label\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Thyroid_Cancer\",\n          \"Colon_Cancer\",\n          \"Lung_Cancer\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 996,\n        \"samples\": [\n          \"\\\"The normalized results are expressed as the relative mRNA level. The comparison between pre-/post-treatment groups was performed by modified paired T-test using the limma package. Fluorescence in situ hybridization (FISH) Samples were tested for ALK rearrangements by FISH (Vysis ALK Break Apart FISH Probe Kit) as previously described30. Gene expression analysis RNA from cell lines and controls was prepared labeled and hybridized to Illumina HT-12 array. For analysis the sample probe profile data in the GeneSpring export format was transformed to log-2 scale and normalized using quantile method by applying beadarray package31 in BioConductor 2.11. Four duplicated samples were averaged to reduce the total sample size to 9 across three groups. The comparison between drug sensitive and drug resistant groups was performed using limma package. The significantly changed probes were identified by moderated t statistics. The p-values from moderated t-tests were adjusted by Benjamini and Hochberg's method to control false discovery rate. The microarray data reported in this  have been deposited in NCBI's Gene Expression Omnibus (GEO) database www.ncbi.nlm.nih.gov/geo (Accession no. GSE49508 URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49508). Xenograft studies Nude mice (nu/nu; Harlan Laboratories) were used for in vivo studies and were cared for in accordance with guidelines approved by the Memorial Sloan-Kettering Cancer Center Institutional Animal Care and Use Committee and Research Animal Resource Center. 8 week old female mice were injected subcutaneously with 5 million H3122 cells together with matrigel. Once tumors reached an average volume of 100 mm3 mice were randomized to the different treatment cohorts. For the experiment in Supplementary Fig. 1f mice were randomized to receive either crizotinib alone MAb391 alone crizotinib + MAb391 or vehicle control (n = 6 for vehicle alone crizotinib and crizotinib + MAb391. n = 5 for MAb391 only). Crizotinib was administered at 50 mg kg?1 p.o. daily \\u0097 5 days. MAb391 was administered at 1 mg i.p. every 3 days. For the experiment in Fig. 6b mice were randomized to receive crizotinib alone (50 mg kg?1 p.o. daily \\u0097 5 days) LDK-378 alone (50 mg kg?1 p.o. daily \\u0097 5 days) or vehicle control (n = 5 for Crizotinib and LDK-378 n = 4 for vehicle control). Mice were observed daily throughout the treatment period for signs of morbidity/mortality. Tumors were measured twice weekly using calipers and volume was calculated using the formula: length \\u0097 width2 \\u0097 0.52. Body weight was also assessed twice weekly. P values were determined with the Wilcoxon Rank Sum test. EML4-ALK (E13;A20) transgenic mice Genetically engineered mice harboring the EML4-ALK E13;A20 fusion variant has been previously reported13. Three month old mice from both genders were used in the described studies. All animal treatment studies were reviewed and approved by the IACUC at the Dana-Farber Cancer Institute. Tumor Biopsy Samples All patient tumor biopsy samples were obtained under Institutional Review Board (IRB) approved protocols (Vanderbilt University IRB# 050644 Memorial Sloan-Kettering Cancer Center IRB #10-136 University Hospital of Cologne IRB #06037 Peter MacCallum Cancer Center IRB#08/71). Written informed consent was obtained from all patients. All samples were deidentified and protected health information was reviewed according to the Health Insurance Portability and Accountability Act (HIPAA) guidelines. For the index patient's tumor clinical genotyping was performed using the SNaPshot platform as previously described32. Immunohistochemistry Tumors were pathologically identified and classified according to WHO guidelines. Briefly 3 ?m thick sections of FFPE tumors were deparaffinized. For pIGF-1R staining antigen retrieval was performed by boiling the section in citrate buffer at pH 6 for 25 minutes. For IRS-1 staining no pretreatment was necessary. Primary antibodies were used as follows: pIGF-1R (pY1161) (Ab39398 1:100 pH 6 Abcam Inc.) IRS-1 (Ab40777 1:100 Abcam Inc.). Corresponding secondary antibodies and detection kits were used (Enhancer: post antibody blocking for Bright Vision plus; Immuno Logic c-DPVB blocking and Polymer: Poly-HRP-GAM/R/R IgG; Immuno Logic c-DPVB999HRP BrightVision+ cat #DPVB999HRP ImmunoLogic Duiven The Netherlands www.immunologic.nl) and stained on an automated stainer (LabVision Autostainer 480S Thermo Scientific). Staining intensities were individually evaluated by 3 independent observers. Supplementary Material 1 Acknowledgements This work was supported by the VICC Cancer Center Core grant (P30-CA68485) a career development award from the Vanderbilt Specialized Program of Research Excellence in Lung Cancer grant (CA90949) NCI grants R01CA121210 and P01CA129243 and by the Joyce Family Foundation. CML was additionally supported by an NIH K12 training grant (K12 CA9060625) an ASCO Young Investigator Award a Uniting Against Lung Cancer grant and a Damon Runyon Clinical Investigator Award. CML was the Carol and Jim O'Hare chief fellow from 7/1/2011 through 6/30/2012. LCH and RB were supported by the Deutsche Forschungsgemeinschaft (SFB 832 Tumormicromilieu) and the German Cancer Aid (CIO K\\u00b6ln Bonn).\\\"\",\n          \"\\\"confidence. If you choose not to take part in this survey it will not affect the care you receive from the NHS in any way. Please do not write your name and address anywhere on the questionnaire as this information is not required. No information you give in this questionnaire will be shared in a way that allows you to be identified. How to complete the survey and how long it will take. The questionnaire is short and will take 5\\u009310?min to complete. Please try to answer every question. Please return your questionnaire even if you have not answered every question. If English is not your first language or if you if you have difficulty understanding the questions then please ask a relative or carer to help you complete the questionnaire. Questions or help? If you have any questions please contact your local lung clinical nurse specialist team. Please select one answer to each question by placing a in the appropriate box. There is space at the end of the survey for you to write any comments. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. Abdel-Rahman M Stockton D Rachet B Hakulinen T Coleman MP 2009 What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable Br J Cancer 101 (Suppl 2 S115 S124 19956155 Aveling EL Martin G Jimnez Garc\\u00ada S Martin L Herbert G Armstrong N Dixon-Woods M Woolhouse I 2012 Reciprocal peer review for quality improvement: an ethnographic case study of the Improving Lung Cancer Outcomes Project BMJ Qual Saf 21 1034 1041 Beckett P Woolhouse I Stanley R Peake MD 2012 Exploring variations in lung cancer care across the UK-the \\u0098story so far' for the National Lung Cancer Audit Clin Med 12 14 18 22372213 Department of Health2012National Cancer Patients' Experience Survey Programme 2012/13. England. Health And Social Care Information Centre2012National Lung Cancer Audit Report. Institute for Healthcare Improvement2003The Breakthrough Series: IHI's Collaborative Model for Achieving Breakthrough Improvement. Boston. Khakwani A Rich AL Powell HA Tata LJ Stanley RA Baldwin DR Duffy JP Hubbard RB 2013 Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit Br J Cancer 109 (8 2058 2065 24052044 Kwon S Florence M Grigas P Horton M Horvath K Johnson M Jurkovich G Klamp W Peterson K Quigley T Raum W Rogers T Thirlby R Farrokhi E Flum D 2012 Creating a learning healthcare system in surgery: Washington State's Surgical Care and Outcomes Assessment Program (SCOAP) at 5 years Surgery 151 146 152 22129638 National Institute for Health and Care Excellence 2011 The Diagnosis And Treatment Of Lung Cancer (Update Of Nice Clinical Guideline 24) Clinical guidelines CG121 London UK Pronovost P Needham D Berenholtz S Sinopoli D Chu H Cosgrove S Sexton B Hyzy R Welsh R Roth G Bander J Kepros J Goeschel C 2006 An intervention to decrease catheter-related bloodstream infections in the ICU N Engl J Med 355 2725 2732 17192537 Roberts CM Stone RA Buckingham RJ Pursey NA Lowe D Potter JM 2012 A randomized trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project: three-year evaluation J Eval Clin Pract 18 (3 599 605 21332611 Walters S Maringe C Coleman MP Peake MD Butler J Young N Bergstr\\u00b6m S Hanna L Jakobsen E K\\u00b6lbeck K Sundstr\\u00b8m S Engholm G Gavin A Gjerstorff ML Hatcher J Johannesen TB Linklater KM McGahan CE Steward J Tracey E Turner D Richards MA Rachet B ICBP Module 1 Working Group 2013 Lung cancer survival and stage at diagnosis in Australia Canada Denmark Norway Sweden and the UK: a population-based study 2004-2007 Thorax 68 551 564 23399908 Wise J 2010 Health atlas shows large variations in care in England BMJ 341 c6809 c6809  Study timelines.  Consort diagram disposal of eligible trusts including screening randomisation and follow-up.  Run chart showing the waiting times from the multidisciplinary team meeting to the first treatment for 10 consecutive small-cell lung cancer patients following the implementation of the quality improvement plan at one trust in the intervention group.  Mean change in national lung cancer audit metrics from baseline (2009) to 2011. P=0.055 active treatment\\u0094intervention vs controls. Intervention n=31 trusts control n=47 trusts and non-intervention (control and non-participants combined) n=66 trusts. Abbreviations: CNS clinical nurse specialist; MDT multidisciplinary team; SCLC small-cell lung cancer.  Total patient questionnaire scores by the multidisciplinary team in the intervention group at baseline (pre) and at the end of the study (post). A low score indicates better experience. Each symbol represents the mean score for each trust in the intervention group. The maximum possible score for the questionnaire is 11.  Quality improvement plan themes Quality improvement plan theme Number of plans Multidisciplinary team effectiveness 31 Diagnostic pathways 13 Treatment pathways 9 Access to clinical nurse specialists 8 Clinical trial recruitment 4 Patient experience 2  Baseline (2009) national lung cancer audit indicators   Control ( n =47) Intervention ( n =31) Excluded ( n =67) P -value   Mean (%) s.e.m. Mean (%) s.e.m. Mean (%) s.e.m. Control vs intervention vs non-participant control vs intervention Case ascertainment 158.1 38.6 122.0 7.2 107.4 3.6 0.220 0.455 Discussed at the MDT meeting 95.2 0.7 93.7 1.7 90.9 1.9 0.155 0.370 Histological confirmation rate 75.7 1.2 76.4 1.8 78.4 1.6 0.409 0.739 Active treatment 59.5 1.2 55.9 2.2 59.5 1.5 0.305 0.131 Surgery (all cases) 13.4 0.6 13.0 0.8 14.2 0.7 0.469 0.648 SCLC (chemo) 65.1 2.2 66.5 3.9 63.3 2.7 0.746 0.733 Seen by CNS 70.3 3.8 76.6 3.2 58.3 4.2 0.007 0.243 CNS present diagnosis 44.0 3.8 49.4 5.4 38.7 3.8 0.237 0.403 Abbreviations: CNS=clinical nurse specialist; MDT=mulitdisciplinary team; SCLC=small-cell lung cancer. Data are shown as mean and s.e. proportion of patients. BMC Cancer BMC Cancer BMC Cancer 1471-2407 BioMed Central 24386906 3893473 1471-2407-14-3 10.1186/1471-2407-14-3 Study Protocol Study protocol of a randomized controlled trial comparing Mindfulness-Based Stress Reduction with treatment as usual in reducing psychological distress in patients with lung cancer and their partners: the MILON study Schellekens Melanie PJ 1 Melanie.Schellekensradboudumc.nl van den Hurk Desiree GM 2 Desiree.vandenHurkradboudumc.nl Prins Judith B 3 Judith.Prinsradboudumc.nl Molema Johan 2 Johan.Molemaradboudumc.nl Donders A Rogier T 4 Rogier.Dondersradboudumc.nl Woertman Willem H 4 Willem.Woertmanradboudumc.nl van der Drift Miep A 2 Miep.vanderDriftradboudumc.nl Speckens Anne EM 1 Anne.Speckensradboudumc.nl 1Department of Psychiatry Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 2Department of Pulmonary Diseases Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 3Department of Medical Psychology Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 4Department of Epidemiology Biostatistics and Health Technology Assessment Radboud University Nijmegen Medical Centre Nijmegen The Netherlands 2014 3 1 2014 14 3 3 28 6 2013 19 12 2013 Copyright  2014 Schellekens et al.; licensee BioMed Central Ltd. 2014 Schellekens et al.; licensee BioMed Central Ltd. This is an open access  distributed under the terms of the Creative Commons Attribution License (http://creativecommons./licenses/by/2.0) which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Background Lung cancer is the leading cause of cancer death worldwide and characterized by a poor prognosis. It has a major impact on the psychological wellbeing of patients and their partners. Recently it has been shown that Mindfulness-Based Stress Reduction (MBSR) is effective in reducing anxiety and depressive symptoms in cancer patients. The generalization of these results is limited since most participants were female patients with breast cancer. Moreover only one study examined the effectiveness of MBSR in partners of cancer patients. Therefore in the present trial we study the effectiveness of MBSR versus treatment as usual (TAU) in patients with lung cancer and their partners. Methods/Design A parallel group randomized controlled trial is conducted to compare MBSR with TAU. Lung cancer patients who have received or are still under treatment and their partners are recruited. Assessments will take place at baseline post intervention and at three-month follow-up. The primary outcome is psychological distress (i.e. anxiety and depressive symptoms). Secondary outcomes are quality of life (only for patients) caregiver appraisal (only for partners) relationship quality and spirituality. In addition cost-effectiveness ratio (only in patients) and several process variables are assessed. Discussion This trial will provide information about the clinical and cost-effectiveness of MBSR compared to TAU in patients with lung cancer and their partners. Trial registration ClinicalTrials.gov NCT01494883. Mindfulness-based stress reduction Lung cancer patients Partners Psychological distress Randomized controlled trial Background With an estimated 1.4 million deaths per year lung cancer is the leading cause of death by cancer worldwide. Even with the best available treatment five-year survival is merely 16% and about 60 to 70% of patients die within the first year after diagnosis [1]. This poor prognosis is often caused by a late diagnosis as the presentation usually occurs when the lung cancer is advanced. Patients may develop burdensome symptoms like pain dyspnoea fatigue and cough and they may undergo radical treatment including surgery chemo- and radiotherapy. Not surprisingly lung cancer has a major impact on the psychological wellbeing of patients and their family. Akechi and colleagues [2] showed that 19% of patients with advanced lung cancer meets the criteria of psychiatric disorders especially depressive and adjustment disorders. Of patients who had been successfully treated for lung cancer 15% met the criteria for a minor or major depressive disorder [3]. The prevalence rate of depressive and anxiety symptoms among lung cancer patients ranges from 20 to 47% [4-7]. Compared to patients with other cancer diagnoses lung cancer patients report the highest rates of distress (43 to 58%) [89] resulting in a lower quality of life [10]. Family friends and especially partners of patients with lung cancer also have to deal with its psychological impact [11-14]. Partners not only provide emotional and practical support they also have to cope with their own concerns including the uncertainty regarding the course of the illness and the fear of losing their partner [15]. More than 50% of partners of lung cancer patients report negative emotional effects of caregiving [16]. Around 40% of partners of patients with advanced lung cancer report high levels of distress [17]. The relationship between patient and partner can also be affected by the cancer. It has been shown that some partners report a lower quality of their relationship after the diagnosis of lung cancer [18]. Though numerous studies examined the psychological distress of lung cancer patients and their partners [2-22] not much research is done on how to alleviate distress in these groups [23]. In addition the available studies on managing the psychosocial care needs of cancer patients and their families have focused on care at the very end of life (e.g. [24-26]). Recently studies have demonstrated that palliative care initiated early in treatment improves the quality of life and depressive symptoms of lung cancer patients [1027]. This stresses the importance of integrating psychosocial care for lung cancer patients and their partners early in the treatment rather than instigating it once life-prolonging therapies fail. In the past ten years MBSR has become a promising psychosocial intervention for cancer patients. Mindfulness is defined as intentionally paying attention to moment-by-moment experiences in a non-judgmental way [28]. MBSR is an 8-week group-based training consisting of meditation practices such as the bodyscan gentle yoga sitting and walking meditation. By repeatedly bringing attention back to the current experience participants gradually learn to disengage from dysfunctional thoughts and directly experience the emotions and bodily sensations of the present moment. MBSR aims to provide participants with the ability to step back from ruminating about the past or worrying about the future and simply allow experiences to unfold [2829]. A recent meta-analysis [30] of 13 nonrandomized studies and 9 randomized controlled trials (RCT) concluded there is positive evidence for the use of mindfulness-based interventions in reducing psychological distress in cancer patients. Among the RCT\\u0099s a reduction in symptom severity was found for both anxiety and depression corresponding to moderate pooled controlled effect sizes (Hedges\\u0099s g = 0.37 and Hedges\\u0099s g = 0.44 respectively) [30]. Though mindfulness-based interventions seem to be effective the authors note that across studies the majority of participants were women (85%) and diagnosed with breast cancer (77%). Compared to breast cancer patients patients with lung cancer are more often male older and have a poorer prognosis. Furthermore of these 22 studies only one study included the partners of the patients showing that partners also benefit from the MBSR training [31]. This is quite surprising since partners of cancer patients also report high levels of distress [32]. Aims The aim of the Mindfulness for Lung Oncology Nijmegen (MILON) study is to examine the effectiveness of MBSR compared to TAU in reducing psychological distress in patients with lung cancer and their partners. We hypothesize that patients in the MBSR group will report a lower level of psychological distress (i.e. anxiety and depressive symptoms) higher levels of quality of life quality of relationship and spirituality than those in the TAU group. Medical and societal costs will be lower in the MBSR versus TAU group. We expect partners in the MBSR group to report a lower level of psychological distress and higher levels of caregiver appraisal relationship quality and spirituality than their counterparts in the TAU group. With regard to the working mechanisms of the MBSR programme we will examine changes in mindfulness skills self-compassion rumination intrusion avoidance and adherence to MBSR. Methods/Design Study design The design of the \\u0098MILON\\u0099 study is a parallel group randomized controlled trial with an embedded process study. Participants are randomized between MBSR and TAU. The study protocol has been approved by our ethical review board (CMO Arnhem-Nijmegen) and registered under number 2011\\u0093519. Participants and procedure Patients and partners are recruited at the outpatient \\\"\",\n          \"\\\"dramatic spread of Coronavirus Disease  COVID19 has profound impacts on every continent and life Due to humantohuman transmission of COVID19 nuclear medicine staffs also cannot escape the risk of infection from workplaces Everystaff in the nuclear medicine department must prepare for and respond to COVID19 pandemic which tailored to the characteristics of our profession This  provided the guidance prepared by the Korean Society of Nuclear Medicine KSNM incooperation with the Korean Society of Infectious Disease KSID and Korean Society for HealthcareAssociated InfectionControl and Prevention KOSHIC in managing the COVID19 pandemic for the nuclear medicine department We hope that thisguidance will support every practice in nuclear medicine during this chaotic periodKeywords Coronavirus  COVID19  Nuclear medicine  Prevention and control  Practice guideline HoYoung Leedebobkrgmailcom Department of Nuclear Medicine CHA Bundang Medical CenterCHA University of Medicine Professor Pocheon Republic ofKorea Department of Nuclear Medicine Seoul National UniversityBundang Hospital Professor Seongnam Gyeonggido Republic ofKorea Department of Nuclear Medicine Samsung Medical CenterSeoul Republic of Korea Department of Nuclear Medicine Seoul National UniversityHospital Seoul Republic of Korea Department of Nuclear Medicine Chosun University HospitalGwangju Republic of Korea Department of Nuclear Medicine Korea University Guro HospitalSeoul Republic of Korea Department of Nuclear Medicine Hanyang University Guri HospitalSeoul Republic of Korea Department of Nuclear Medicine National Cancer CenterGoynag Republic of Korea Department of Nuclear Medicine Seoul Medical CenterSeoul Republic of Korea Division of Nuclear Medicine Department of RadiologyEunpyeong St Mary\\u0099s Hospital College of Medicine The CatholicUniversity of Korea Seoul Republic of Korea Department of Nuclear Medicine Soonchunhyang University SeoulHospital Bucheon Republic of Korea Department of Nuclear Medicine Inje University Haeundae PaikHospital Busan Republic of Korea Department of Nuclear Medicine Keimyung University DongsanMedical Center Daegu Republic of Korea Department of Nuclear Medicine Soonchunhyang UniversityCheonan Hospital Cheonan Republic of Korea Department of Nursing Soonchunhyang University BucheonHospital Bucheon Republic of Korea Division of Infectious Disease Department of Internal MedicineKangdong Sacred Heart Hospital Hallym UniversityChuncheon Republic of Korea Department of Nuclear Medicine Soonchunhyang UniversityBucheon Hospital Bucheon Republic of Korea Department of Nuclear Medicine Korea University Anam Hospital Korean Society of Nuclear Medicine Quality Control CommitteeSeoul Republic of KoreaBucheon Republic of Korea 0cIntroductionSince the first reports of Coronavirus Disease  COVID in Wuhan China the infection had spread worldwiderapidly and COVID19 has reached pandemic levels InSouth Korea since its outbreak in February  COVID has affected profoundly every aspect of communities Thehumantohuman transmission of COVID19 provides challenges for all healthcare facilities and healthcare providersIn the face of the COVID19 pandemic the Korean Societyof Nuclear Medicine KSNM Korean Society of InfectiousDisease KSID and Korean Society for HealthcareAssociated Infection Control and Prevention KOSHIC haveprepared the guidance for the nuclear medicine department tominimize confusion and ensure that nuclear medicine physicians and technicians continue to provide their services whileprotecting the patients and workers and preventing the transmission of the virus The Quality Control Committee ofKSNM reviewed several reports and recommendations previously published by the European Association of NuclearMedicine EANM [] Society of Nuclear Medicine andMolecular Imaging SNMMI American Society of NuclearCardiology ASNC [] International Atomic Energy AgencyIAEA and others [\\u0093] This guidance is basically in compliance with the COVID19 guidelines of the Korea Centersfor Disease Control and Prevention KCDC [\\u0093] Finallythis document was prepared in cooperation with KSID andKOSHIC KSNM emphasize that this guidance must be considered in the context of following the state and hospital infection control policies and flexibly applied according tochanges in circumstances and evidenceGeneral Principles During COVID19PandemicIn a pandemic situation such as COVID19 if necessarythe condition of the scheduled patient can be checked inadvance to adjust the examination schedule Nonurgent elective studies or therapy should be postponed in COVID19confirmed or COVID19suspectedpatients Rescheduling the studiestherapy must be donein a discussion with the referring clinicians Only urgent studies or therapy could be performed inCOVID19confirmed or COVID19suspected patientswhenever clinically appropriate The priority of studytherapy should be based on a casebycase indepth discussion between nuclear medicine physicians and referring clinicians In case of performing the urgent studiestherapy consult with the infection control offices of eachinstitution to comply with the infection control rules ofownNucl Med Mol Imaging  \\u0093 COVID19suspected patients should undergo COVID testing before performing the studiestherapy Lung ventilation scan should not be performed in anyCOVID19confirmed or COVID19suspected patients Lowdose radioiodine therapy may be considered in caseof acute hyperthyroidism patients who are unable to tolerate antithyroid medications As lowdose radioiodinetherapy lower than  GBq of I131 can be performedin an outpatient setting in South Korea COVID19infected patient can be administrated lowdoseradioiodine in the isolation room or negative pressureroom without any additional monitoring related toradioiodine therapyConsideration During the StudyTherapy Patient transportationScheduling COVID19confirmed or COVID19suspected patient as last study of the day to preventcrossinfection in the nuclear medicine department Ensure that other patients or caregivers should notaccess the nuclear medicine department to minimizethe exposure to COVID19 patient during the studytherapy Transfer the COVID19infected patient to the nuclear medicine department using negative pressuretransport bag to minimize exposure and contact todroplet COVID19 patients should wear masks at all timesof procedures If necessary add gowns gloves etc Devices and scanner management Mainly use disposable instruments or items Do notreuse disposable items such as oxygen masks nasalprongs suction tubes or suction lines The protocolfor reusable devices is as follows Cleaning After use the equipment contaminated with blood bodyfluids secretions and feces should be delivered to awashing room with care not to contaminate the surrounding environment The washing place should be separated from the spaceused for cleaning other items or other patients After immersing the contaminated equipment in a washing spacewash the product carefully to avoid splashing Wash enough to remove blood body fluids secretionsand feces from remaining 0cNucl Med Mol Imaging  \\u0093 Staff undertaking cleaning should wear KF94 or N95masks longsleeved waterproof gowns goggles or faceshields hats shoe covers or rubber boots and doublegloves outer gloves are rubber gloves Disinfection and sterilization Depending on the risk level of the device according tothe Spaulding Classification of medical equipmentdevices noncritical devices require lowlevel disinfectionsemicritical devices require highlevel disinfectionsterilization and critical devices must be sterilized Disinfectants and sterilization methods by device classification should be followed in accordance with the notificationof the Ministry of Health and Welfare   Be sure to check the disinfectant manufacturer\\u0099s recommendations The recommended disinfection process suchas dilution and application time of disinfectant and theeffective period and concentration of disinfectant arestrictly followed Laboratory and scan room management Only the minimum number of staffs should be placedin the nuclear medicine department All participatingstaffs should wear appropriate personal protectiveequipment PPE eye protection with goggles or faceshield medical protective masks N95KF94 or equivalent respirator disposable latex gloves disposablegown disposable shoe covers etc Cover the scanner couch or other equipment with aplastic cover to prevent contamination Every effort should be made to minimize theCOVID19 exposure to medical staff during injection of radiopharmaceuticalsSelect the protocol with the shortest duration of uptake time and scan time to minimize the time spentby the COVID19 patient in the departmentIn case of studies requiring an uptake phaseCOVID19 patients should be waiting in separatespace If possible COVID19 patients wait in negative pressure transport bag If negative pressuretransport bag is not available use bed or stretcherin waiting room with disposable cover Considerusing standard radiopharmaceutical dose to shortenthe procedure time After the completion of image acquisition the scanroom and patient\\u0099s space area should be disinfectedaccording to the standard protocol After image acquisition remove the plastic cover ofthe scanner and disinfect the scanner surface Remove and discard PPE adequately when leavingthe camera room or care area and immediately perform hand hygieneIn case of performing the radiolabeling of theCOVID19 patients\\u0099 blood products every processwith infectious materials openingstirringmixingdispensing COVID19 patient\\u0099s blood sampleradiolabeling etc should be done in class II biosafety cabinet according to the Biosafety Level Regulation Disinfection of laboratory with properdisinfectants  ethanol  hydrogen peroxide or  ppm sodium hypochlorite should bedone Used PPE and disposable covers are removed withcaution not to contaminate the clean area and disposed in a container for biosafety waste Employee management All employees should be trained in the preventionand management of COVID19 infection and adhereto the rules of infection prevention Considering the skill level fatigue etc of the working staff sufficient personnel are allocated to securethemPriority from exemption is given to employees withhighrisk underlying diseases such as diabetesmellitus chronic obstructive pulmonary diseaseCOPD endstage renal disease ESRD chroniccardiac disease etc or pregnant women Cleaning and environmental management General principle Personnel responsible for cleaning or disinfectionshould complete the infection preventioneducation Employees should wear PPE KF94 or N95 respirators fullbody protective clothing or aprons goggles or face shields shoe covers or rubber bootsdouble gloves outer gloves are rubber gloveswhen cleaning or disinfectingIf there are organic substances on the surface of theenvironment it cannot be properly disinfectedTherefore wipe the surface before disinfecting theenvironmentIn order to prevent the possibility of microbialspraying cleaning should be performed using acleaning solution or a mop moistened with a disinfectant rather than a cleaning method using abroom or a vacuum cleanerInstead of spraying disinfectants thoroughly cleanthe surface of the environment using a clean towelmoistened with the disinfectant or a commerciallyavailable disinfecting tissue towel 0cNucl Med Mol Imaging  \\u0093 Use cleaning tools as disposable as possible or exclusively However when the cleaning tool isreused the used cleaning tool is sterilized usingan appropriate disinfectant and then dried andstored Disinfection of a patient\\u0099s space areaIn the case of the space area used by the patientmark the place where contamination was confirmedbefore cleaning and disinfecting the surface andseal the contaminated object to prevent others frombeing exposed Ventilation before during and after cleaningdisinfection disinfection after ventilation for  hbased on  air cycles per hour Wear PPE Wipe with a cloth cloth etc wet withthe diluted disinfectant Wipe the touched wall surface and all frequently used areas and keep it for atleast  min After then wipe the surface with acloth dampened with clean water cloth etcResumption of use Consider the characteristics ofeach type of disinfectant used and the purpose of thefacility After disinfection the virus is killed but thedecision at the time of resumption of use cannot beapplied in batch due to different characteristics ofdisinfectants so it is necessary to consider the precautions for each productFor details on disinfecting methods such as surfacedisinfection and washing refer to \\u009cDisinfectionGuidelines to Prevent the Spread of COVID19 atPublic and Multipurpose Facilities 3rd edition\\u009dRefer to the method of disinfecting the patient spaceareaSelect an environmental disinfectant Select an approved or declared disinfectant by the Ministry ofEnvironment and follow the usage usage and precautions for each product Disinfectant list of the Ministry of Environmenthttpecolifemegokr Precautions when using environmentaldisinfectants Select the disinfectant after confirming informationsuch as approval from the Ministry of Environmentand Environment When using environmental sterilizers make sure tofollow the manufacturer\\u0099s recommendations suchas checking the expiration date safe usage for eachproduct and precautions and preparing the diluentaccording to the manufacturer\\u0099s instructions The disinfecting method of sprayinginjecting disinfectant is not applied to surface disinfectionbecause it causes aerosol infection increased riskof inhalation and the range of contact between thedisinfectant and the surface is insufficient so thedisinfecting effect is insufficient Disinfectant hazard information must be checkedand used carefully Do not mix different disinfectants Do not placenear flammable materials Disinfectant should beused in a wellventilated area As the disinfection effect may decrease over timedilute as much as necessary and use it immediatelyDo not store the remaining amount and discard itimmediately Laundry managementStore clean laundry in a separate space Employees handling laundry should be trained toprevent infection Employees handling contaminated laundry shouldwear PPE N95 masks or equivalent respiratory protection gowns gloves overshoes etc and performhand hygiene after removing PPE The laundry used for the patient is disposed of according to the relevant regulations see WasteManagement Act Medical Institution LaundryManagement Rules etc Thoroughly ensure that pathogens are not exposed topersonnel handling the laundry or surrounding environment during the entire process of collectingtransporting and washing laundry Waste management Waste related to COVID19 patients is managed bythe rules of hospital infectious control policySharp tools such as needles or blades are collectedin containers for impervious and nonpermanentwaste and containers should be stored in the placewhere the items are usedSimple infectious waste contaminated or possiblycontaminated with COVID19 patients\\u0099 sample isautoclaved and discarded Radioactive waste shouldbe discarded in compliance with national regulationwith caution not to contaminate the staff or areaConclusionConsidering that outbreaks of novel viruses have been periodically appearing these days nuclear medicine staffs should getused to guidance and policies for infectious disease in working 0cNucl Med Mol Imaging  \\u0093place to protect patients worker themselves and furthermorevaluable medical resources Basically this guidance can beapplied in case of any other humantohuman transmissiondisease for operating the nuclear medicine department Alsoalways bear in mind the rapid change in the situation thisguidance should be used in conjunction with the currentgovernment and local hospital policiesCompliance with Ethical StandardsConflict of InterestJiIn Bang HoYoung Lee Young Seok ChoHongyoon Choi Ari Chong Jae Sun Eo Ji Young Kim Tae SungKim HyunWoo Kwon Eun Jeong Lee Eun Seong Lee Hye LimPark Soo Bin Park Hyekyung Shim BongIl Song Ik Dong YooKyung Jae Lee Hong Jae Lee Su Ha Han Jin Seo Lee Jung Mi Parkand Sung Hoon Kim declare that they have no conflict of interestEthical Approval This work does not contain any studies with humanparticipants or animals performed by any of the authorsInformed Consent Not applicableReferences Paez D Gnanasegaran G Fanti S Bomanji J Hacker M SathekgeM et al COVID19 pandemic guidance for nuclear medicine departments Eur J Nucl Med Mol \\u0093 Skali H Murthy VL AlMallah MH Bateman TM Beanlands RBetter N et al Guidance and best practices for nuclear cardiologylaboratories during the coronavirus disease  COVID19 pandemic an information statement from ASNC and SNMMI J NuclCardiol \\u0093 httpsdoiorg101007s12350020021232 Huang HL Allie R Gnanasegaran G Bomanji J COVID19\\u0093nuclear medicine departments be prepared NuclMedCommun MossaBasha M Medverd J Linnau K Lynch JB Wener MHKicska G et al Policies and guidelines for COVID19 preparedness experiences from the University of Washington Radiology httpsdoiorg101148radiol2020201326 Zhang X Shao F Lan X Suggestions for safety and protectioncontrol in Department of Nuclear Medicine during the outbreak ofCOVID19 Eur J Nucl Med Mol \\u0093 Buscombe JR Notghi A Croasdale J Pandit M O'Brien J GrahamR et al COVID19 guidance for infection prevention and controlin nuclear medicine Nucl Med Commun \\u0093 Standard guideline for healthcareassociated infection control andprevention Korean Center for Disease Control and Prevention andKorean Society for HealthcareAssociated Infection Control andPrevention  httpcdcgokrCDCcmscontentmobile2675626_viewhtml Accessed 2nd Jun  Korean Society for HealthcareAssociated Infection Control andPrevention Korean Center for Disease Control and Preventionhttpwwwcdcgokrboardesmida20507020000bid0019actviewlist_no366579 Accessed 2nd Jun  Guidelines in response to coronavirus disease for local governmentKorea Centers of Disease Control and Prevention2020 httpswwwcdcgokrboardboardesmida20507020000bid0019actviewlist_no367279tagnPage1 Accessed 2ndJun  Disinfection guidelines to prevent the spread of COVID19 at public and multipurpose facilities Korea Centers of Disease Controland Prevention  httpswwwcdcgokrboardboardesmida20507020000bid0019 Acessed 15th Jun Publisher\\u0099s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations 0c\\\"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"processed_text\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 991,\n        \"samples\": [\n          \"['activation', 'naturalphytochemicals', 'overviewconcetta', 'iside', 'marika', 'scafuro', 'angela', 'nebbioso', 'lucia', 'altucci', 'department', 'precision', 'medicine', 'university', 'campania', 'naples', 'italysirtuins', 'class', 'iii', 'histone', 'deacetylases', 'whose', 'enzymatic', 'activity', 'dependent', 'nadas', 'cofactor', 'sirtuins', 'report', 'modulate', 'numerous', 'activity', 'control', 'geneexpression', 'dna', 'repair', 'metabolism', 'oxidative', 'stress', 'response', 'mitochondrial', 'functionand', 'biogenesis', 'deregulation', 'expression', 'andor', 'action', 'may', 'lead', 'event', 'involve', 'development', 'several', 'human', 'pathology', 'includingcancer', 'neurodegeneration', 'cardiovascular', 'disease', 'study', 'member', 'thisclass', 'enzyme', 'sirtuin', 'whose', 'expression', 'associate', 'increasinginsulin', 'sensitivity', 'implicate', 'tumorigenic', 'anticancerprocesses', 'report', 'regulate', 'essential', 'metabolic', 'pathway', 'suggest', 'thatits', 'activation', 'might', 'disorder', 'metabolism', 'via', 'regulation', 'modulation', 'autophagy', 'implicate', 'cellular', 'response', 'tocaloric', 'restriction', 'lifespan', 'extension', 'recent', 'year', 'interest', 'focus', 'modulators', 'lead', 'discovery', 'novel', 'small', 'moleculestargeting', 'activity', 'review', 'examine', 'compound', 'natural', 'origin', 'recentlyfound', 'upregulate', 'activity', 'polyphenolic', 'product', 'fruit', 'vegetablesand', 'plant', 'include', 'resveratrol', 'quercetin', 'curcumin', 'also', 'discus', 'thepotential', 'therapeutic', 'effect', 'natural', 'compound', 'prevention', 'treatmentof', 'human', 'disorder', 'particular', 'emphasis', 'metabolic', 'impactkeywords', 'sirtuin', 'natural', 'compound', 'oxidative', 'stress', 'human', 'disorder', 'polyphenolsedited', 'bycecilia', 'battistellisapienza', 'university', 'rome', 'italyreviewed', 'bynarasimham', 'l', 'parinandithe', 'ohio', 'state', 'universityunited', 'statescarmen', 'jeronimoportuguese', 'oncology', 'instituteportugalcorrespondenceangela', 'nebbiosoangelanebbiosounicampaniaitlucia', 'altucciluciaaltucciunicampaniait', 'author', 'share', 'last', 'authorshipintroductionspecialty', 'sectionthis', 'submit', 'totranslational', 'pharmacologya', 'section', 'journalfrontiers', 'pharmacologyreceived', 'april', 'accepted', 'july', 'published', 'august', 'citationiside', 'c', 'scafuro', 'nebbioso', 'andaltucci', 'l', 'activation', 'bynatural', 'phytochemicals', 'overviewfront', 'pharmacol', 'associate', 'genome', 'stability', 'gene', 'transcription', 'metabolicregulation', 'acetylation', 'one', 'characterize', 'histone', 'histoneacetyltransferase', 'hat', 'histone', 'deacetylase', 'hdac', 'enzyme', 'control', 'level', 'histoneacetylation', 'modulate', 'gene', 'expression', 'cavalli', 'heard', 'sirtuins', 'sirt', 'enzyme', 'class', 'iii', 'hdacs', 'exhibit', 'different', 'subcellularlocalizations', 'nuclear', 'although', 'isoforms', 'also', 'inabbreviations', 'sirtuin', 'hats', 'histone', 'acetyl', 'transferase', 'hdacs', 'histone', 'deacetylases', 'ros', 'reactive', 'oxygenspecies', 'ppar', 'receptor', 'peroxisome', 'proliferatoractivated', 'receptor', 'nrf', 'nuclear', 'respiratory', 'factor', 'tfam', 'mitochondrialtranscription', 'factor', 'sod', 'superoxide', 'dismutase', 'tnfa', 'tumor', 'necrosis', 'factor', 'iap', 'apoptosis', 'protein', 'inhibitor', 'family', 'mnsod', 'manganese', 'superoxide', 'dismutase', 'rsv', 'resveratrol', 'que', 'quercetin', 'oxldl', 'oxidizedldl', 'bbr', 'berberine', 'cur', 'curcumin', 'cox', 'cytochrome', 'c', 'oxidase', 'type', 'ii', 'diabetes', 'nafld', 'nonalcoholic', 'fatty', 'liverdisease', 'crm', 'caloric', 'restriction', 'mimeticfrontiers', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorsthe', 'cytoplasm', 'mainly', 'cytosolic', 'mitochondrial', 'shuttle', 'nucleus', 'changand', 'guarente', 'enzymatic', 'activity', 'sirts', 'dependent', 'nad', 'acofactor', 'play', 'important', 'role', 'control', 'geneexpression', 'dna', 'repair', 'metabolism', 'oxidative', 'stress', 'responsemitochondrial', 'function', 'biogenesis', 'deregulation', 'theiractivity', 'may', 'lead', 'degenerative', 'event', 'thatunderlie', 'several', 'human', 'pathologiesincluding', 'cancerdiabetes', 'cardiovascular', 'disease', 'haigis', 'sinclair', 'vassilopoulos', 'waldman', 'study', 'member', 'enzymatic', 'class', 'regulates', 'metabolic', 'pathway', 'cell', 'survivalcellular', 'senescence', 'act', 'thepathogenesis', 'chronic', 'condition', 'diabetes', 'well', 'aspulmonary', 'neurodegenerative', 'cardiovascular', 'diseasesindeed', 'report', 'play', 'key', 'role', 'intumorigenesis', 'oncogene', 'tumor', 'suppressor', 'dependingon', 'context', 'biasonlauber', 'able', 'tocontrol', 'process', 'via', 'deacetylation', 'lysine', 'group', 'ofhistone', 'nonhistone', 'protein', 'include', 'know', 'transcriptionfactors', 'foxo', 'myod', 'kupis', 'chronic', 'cause', 'oxidative', 'damage', 'increasesthe', 'risk', 'many', 'chronic', 'disordersincluding', 'heartcardiovascular', 'neurodegenerative', 'disease', 'obesity', 'insulinresistance', 'type', 'diabetes', 'geto', 'oxidative', 'stress', 'play', 'key', 'role', 'pathogenesis', 'theseconditions', 'overproduction', 'reactive', 'oxygen', 'speciesros', 'include', 'free', 'radical', 'reactive', 'nitrogen', 'speciesrns', 'lead', 'damage', 'cellular', 'component', 'aslipids', 'protein', 'dna', 'imbalance', 'oxidantsand', 'antioxidant', 'result', 'cellular', 'dysfunction', 'apoptosisand', 'necrosis', 'liguori', 'guard', 'oxidative', 'stress', 'activate', 'genetranscription', 'via', 'deacetylation', 'regulatingtranscription', 'factor', 'nuclear', 'receptor', 'peroxisomeproliferatoractivated', 'receptor', 'ppar', 'nuclear', 'respiratory', 'factornrf', 'mitochondrial', 'transcription', 'factor', 'tfaminvolved', 'modulation', 'biogenesis', 'mitochondrialfunction', 'ren', 'metabolism', 'glucose', 'lipidsrodgers', 'also', 'able', 'regulate', 'expressionof', 'superoxide', 'dismutase', 'sod', 'glutathione', 'peroxidase', 'sun', 'addition', 'since', 'mitochondrial', 'dysfunction', 'lead', 'tothe', 'activation', 'apoptosis', 'directly', 'regulate', 'theapoptotic', 'process', 'modulate', 'acetylation', 'zhang', 'also', 'regulates', 'responsekauppinen', 'modulate', 'acetylation', 'level', 'ofnfkb', 'able', 'control', 'transcription', 'gene', 'asil', 'tumor', 'necrosis', 'factor', 'tnfa', 'factor', 'rodgers', 'ren', 'yeung', 'nfkb', 'also', 'regulatesthe', 'expression', 'gene', 'inhibitor', 'apoptosis', 'proteiniap', 'bcell', 'tumor', 'necrosis', 'factorreceptor', 'tnfr', 'ren', 'protects', 'oxidative', 'stress', 'via', 'regulation', 'offoxo', 'protein', 'acetylation', 'involve', 'antioxidantprocesses', 'apoptosis', 'cell', 'proliferation', 'wong', 'andwoodcock', 'activate', 'foxomssod', 'increase', 'expression', 'manganese', 'superoxidedismutase', 'mnsod', 'catalase', 'counteract', 'oxidativestress', 'promote', 'damage', 'repair', 'gu', 'increase', 'expression', 'mnsod', 'deacetylating', 'enhance', 'cellular', 'antioxidant', 'capacity', 'brunet', 'zhang', 'ren', 'past', 'year', 'evergrowing', 'awareness', 'goodhealth', 'go', 'hand', 'hand', 'healthy', 'balance', 'diet', 'hasencouraged', 'people', 'eat', 'fruit', 'vegetable', 'takesupplements', 'make', 'bioactive', 'compound', 'diet', 'act', 'antioxidantand', 'agent', 'thereby', 'reduce', 'negativeeffects', 'oxidative', 'stress', 'incidence', 'chronicdiseases', 'obesity', 'diabetes', 'cardiovascular', 'disorderswang', 'several', 'moleculesincluding', 'naturalphytochemical', 'compound', 'modulate', 'activitymiceli', 'numerous', 'study', 'provide', 'evidenceof', 'protective', 'effect', 'natural', 'polyphenolic', 'substance', 'suchas', 'resveratrol', 'quercetin', 'curcumin', 'ofnatural', 'nonpolyphenolic', 'substance', 'berberinemccubrey', 'natural', 'polyphenols', 'largestgroup', 'phytonutrients', 'consider', 'potential', 'agent', 'forthe', 'prevention', 'treatment', 'stressrelated', 'oxidative', 'diseasesthey', 'found', 'many', 'plant', 'food', 'fruitsvegetables', 'tea', 'cereal', 'wine', 'longterm', 'intake', 'isassociated', 'health', 'mediterranean', 'diet', 'factlinked', 'reduce', 'risk', 'chronic', 'disease', 'due', 'theconsumption', 'olive', 'oil', 'red', 'wine', 'contain', 'highamounts', 'polyphenols', 'romagnolo', 'selmin', 'evidence', 'support', 'effect', 'ofphytochemical', 'compound', 'come', 'vitro', 'animalstudies', 'human', 'study', 'evaluate', 'longterm', 'impact', 'ofphytomolecules', 'particularly', 'inconsistent', 'interventionalstudies', 'fact', 'limited', 'issue', 'bioavailability', 'andmetabolism', 'however', 'vitro', 'study', 'aim', 'identifyingcellular', 'target', 'link', 'action', 'phytonutrientrich', 'food', 'concentration', 'range', 'nm', '\\u00b5m', 'challenge', 'thetranslatability', 'data', 'ingestion', 'compound', 'factdetected', 'phase', 'ii', 'metabolite', 'blood', 'level', 'notexceed', 'concentration', 'nm', 'range', 'substantial', 'amount', 'thecompounds', 'metabolite', 'degrade', 'colon', 'byintestinal', 'microbiota', 'give', 'rise', 'small', 'phenolic', 'acid', 'andaromatic', 'catabolises', 'absorbed', 'circulatorysystem', 'del', 'rio', 'interesting', 'study', 'show', 'thatthese', 'natural', 'polyphenol', 'nonpolyphenol', 'substance', 'couldaffect', 'expressionactivity', 'table', 'de', 'boer', 'themain', 'mechanism', 'action', 'common', 'polyphenol', 'nonpolyphenol', 'molecule', 'lead', 'antioxidant', 'effect', 'via', 'activation', 'report', 'figure', 'focus', 'natural', 'molecule', 'resveratrolquercetin', 'curcumin', 'berberine', 'elucidate', 'theireffect', 'activation', 'potential', 'treat', 'andorprevent', 'several', 'human', 'pathology', 'mainly', 'associate', 'withmetabolic', 'disorder', 'figure', 'frontiers', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorstable', 'nutraceuticals', 'base', 'action', 'food', 'positive', 'effect', 'bloodlipid', 'antioxidantdark', 'grapesraisins', 'peanutsquercetinberberinecurcuminfisetinanticancer', 'positiveeffect', 'blood', 'antioxidant', 'vegetablesnutsnatural', 'componentof', 'traditionalchinese', 'herbcoptidis', 'rhizomaactive', 'componentin', 'curcuma', 'longaapplespersimmonsgrapes', 'onionskiwi', 'zordoky', 'hung', 'nabavi', 'nabavi', 'wu', 'hung', 'zendedel', 'kim', 'chen', 'natural', 'compounds', 'expression', 'activityresveratrolresveratrol', 'rsv', 'polyphenol', 'found', 'grapesand', 'grape', 'product', 'red', 'wine', 'exerts', 'antioxidant', 'actionwith', 'report', 'cancer', 'preventive', 'property', 'krisetherton', 'rsv', 'also', 'anticancer', 'andantineurodegenerative', 'effect', 'piotrowska', 'roleof', 'rsv', 'immune', 'response', 'modulator', 'demonstrate', 'inboth', 'vitro', 'vivo', 'study', 'reverse', 'immunesenescence', 'old', 'rat', 'reduce', 'response', 'inrodents', 'improve', 'immunological', 'activity', 'cancercells', 'malaguarnera', 'rsv', 'show', 'involve', 'theactivation', 'macrophage', 'cell', 'natural', 'killer', 'cell', 'wellas', 'suppression', 'process', 'regulatory', 'cellsyang', 'svajger', 'jeras', 'effect', 'aredue', 'ability', 'remove', 'rosinhibit', 'cyclooxygenasecox', 'trigger', 'pathway', 'via', 'miceli', 'malaguarnera', 'interrupt', 'axis', 'reduces', 'cytokineproduction', 'inactivate', 'immune', 'cell', 'inhibits', 'factor', 'derive', 'macrophagesmast', 'cellssuch', 'plateletactivating', 'factor', 'tnfa', 'capiralla', 'interaction', 'structure', 'andpromotes', 'binding', 'activity', 'substrate', 'include', 'yeung', 'component', 'nfkb', 'complexwhich', 'regulates', 'activation', 'leukocyte', 'activate', 'rsv', 'inhibits', 'acetylation', 'relaby', 'reduce', 'expression', 'factor', 'tnfa', 'metalloprotease', 'nfkbmediated', 'malaguarnera', 'amp', 'activatedprotein', 'kinase', 'ampk', 'also', 'target', 'rsv', 'activity', 'via', 'regulation', 'cellular', 'level', 'nad', 'thusacting', 'energy', 'sensor', 'price', 'cyclicadenosine', 'monophosphate', 'camp', 'level', 'activate', 'proteinkinase', 'result', 'phosphorylation', 'activation', 'basic', 'mechanism', 'effect', 'activation', 'polyphenol', 'nonpolyphenol', 'moleculesfrontiers', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorsfigure', 'nutraceutical', 'action', 'expression', 'natural', 'substance', 'effect', 'human', 'health', 'regulate', 'action', 'different', 'cellularprocesses', 'wwwpubchemncbinlmnihgovwan', 'activated', 'catalyzes', 'deacetylationand', 'activation', 'thereby', 'promote', 'effectsin', 'metabolism', 'ren', 'different', 'anisms', 'cerevisiae', 'c', 'elegans', 'dmelanogaster', 'express', 'homologous', 'genesrsv', 'treatment', 'able', 'extend', 'life', 'span', 'mammaliansrsv', 'administration', 'improve', 'cellularprocesses', 'axonal', 'protection', 'araki', 'fatmobilization', 'chaplin', 'inhibition', 'nfkbdependent', 'transcription', 'yeung', 'effect', 'areabolished', 'knockdown', 'model', 'numerous', 'studiesinvestigated', 'effect', 'rsv', 'cardiovasculardiseases', 'include', 'hypertension', 'theodotou', 'cardiac', 'ischemia', 'fourny', 'atherosclerosischassot', 'rsv', 'effect', 'blood', 'vesselsreduces', 'prevents', 'thrombus', 'formation', 'andplatelet', 'oxidation', 'zordoky', 'also', 'reducecardiac', 'dysfunction', 'oxidative', 'stress', 'apoptosis', 'inthe', 'heart', 'gupta', 'yamagata', 'addition', 'rsvwas', 'found', 'improve', 'heart', 'kidney', 'damage', 'rat', 'li', 'et', 'protective', 'effect', 'rsv', 'associate', 'anincrease', 'activity', 'deacetylates', 'andactivates', 'mnsod', 'downstream', 'rsvinduced', 'mnsod', 'alsoreduces', 'oxidative', 'stress', 'li', 'recent', 'vitrostudy', 'show', 'rsv', 'reduces', 'hypoxiainduced', 'apoptosis', 'cell', 'activation', 'axishan', 'rsv', 'treatment', 'decrease', 'cortical', 'andhippocampal', 'malondialdehyde', 'level', 'increase', 'sodactivity', 'expression', 'diabetic', 'rat', 'model', 'rsv', 'show', 'activate', 'improve', 'endothelialfunction', 'obese', 'mouse', 'via', 'upregulation', 'ppard', 'expressionactivity', 'ppard', 'mutant', 'mouse', 'cheang', 'hadpreviously', 'observe', 'akt', 'activation', 'together', 'withppard', 'involve', 'vascularization', 'dbdb', 'mouse', 'tian', 'rsv', 'subsequently', 'report', 'increasephosphorylation', 'akt', 'transcriptional', 'activity', 'ppardin', 'aorta', 'wildtype', 'mouse', 'thus', 'support', 'hypothesis', 'interaction', 'strongly', 'decrease', 'lpcinduced', 'mitochondrial', 'ros', 'aortic', 'endothelium', 'mouse', 'cheang', 'taken', 'together', 'highlight', 'effect', 'rsv', 'oxidativestress', 'involve', 'major', 'pathology', 'heart', 'andmetabolic', 'disorder', 'although', 'rsv', 'manycontexts', 'pleiotropic', 'action', 'need', 'well', 'study', 'inorder', 'understand', 'described', 'activity', 'directlydue', 'modulation', 'whether', 'effect', 'always', 'directbecause', 'pleiotropic', 'action', 'rsv', 'clinical', 'trial', 'arecurrently', 'test', 'therapeutic', 'potential', 'wide', 'range', 'ofhuman', 'disease', 'however', 'mechanism', 'described', 'invitro', 'vivo', 'study', 'inhumans', 'gene', 'protein', 'regulation', 'blood', 'musclecells', 'akt', 'signal', 'pathway', 'ghanim', 'brasnyo', 'many', 'clinical', 'study', 'conduct', 'healthy', 'patientsand', 'volunteer', 'use', 'high', 'low', 'dos', 'rsv', 'highlightits', 'potential', 'cardioprotective', 'improvement', 'ofendothelial', 'marker', 'glucosemetabolism', 'nevertheless', 'mechanism', 'action', 'notyet', 'well', 'despite', 'clinical', 'evidence', 'effect', 'thepoor', 'bioavailability', 'rapid', 'metabolism', 'rsv', 'severelylimit', 'potential', 'use', 'molecule', 'clinic', 'research', 'focus', 'identify', 'actual', 'metabolitesor', 'mediator', 'observe', 'effectsto', 'date', 'clinical', 'trial', 'test', 'safety', 'andpharmacokinetics', 'rsv', 'prevention', 'treatment', 'different', 'pathological', 'condition', 'wwwclinicaltrialsgovfrontiers', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorsrestricting', 'search', 'interventional', 'phase', 'studiescompleted', 'terminate', 'clinical', 'trial', 'address', 'theability', 'rsv', 'improve', 'pathological', 'condition', 'ofpatients', 'affected', 'several', 'disease', 'studiestested', 'rsvmediated', 'effect', 'central', 'nervous', 'systemdisorders', 'friedreich', 'ataxia', 'disease', 'metabolic', 'disorder', 'phase', 'clinicaltrial', 'test', 'effect', 'chronic', 'resveratrolsupplementation', 'mg', 'daily', 'day', 'healthy', 'humansand', 'found', 'considerable', 'improvement', 'cognitive', 'performancecerebral', 'blood', 'subjective', 'sleep', 'mood', 'health', 'bloodpressure', 'list', 'complete', 'terminate', 'clinical', 'trial', 'inwhich', 'rsv', 'test', 'metabolic', 'disorder', 'report', 'intable', 'focusing', 'complete', 'clinical', 'trial', 'availableresults', 'evaluate', 'effect', 'rsv', 'metabolicsyndrome', 'demonstrate', 'administer', 'three', 'timesper', 'day', 'mgdie', 'meal', 'rsv', 'able', 'treat', 'andprotect', 'obesity', 'diabetes', 'effect', 'onglucose', 'lipid', 'metabolism', 'blood', 'pressure', 'bodyweight', 'another', 'phase', 'study', 'evaluate', 'theeffects', 'formulation', 'compose', 'rsv', 'hesperetin', 'inobese', 'subject', 'found', 'molecule', 'dietaryinducers', 'glyxalase', 'improve', 'metabolic', 'vascularhealth', 'obese', 'subject', 'xue', 'quercetinthe', 'polyphenol', 'quercetin', 'que', 'natural', 'safe', 'dietary', 'supplementfound', 'glycoside', 'form', 'fruit', 'vegetable', 'nut', 'whichhas', 'antioxidant', 'property', 'nabavi', 'wu', 'recent', 'year', 'community', 'focus', 'thepotential', 'antiproliferative', 'chemopreventive', 'anticarcinogenicactivities', 'que', 'well', 'role', 'modulator', 'geneexpression', 'however', 'que', 'also', 'found', 'potentially', 'toxiceffects', 'include', 'mutagenicity', 'prooxidant', 'activity', 'mitochondrialtoxicity', 'inhibition', 'enzyme', 'involve', 'hormonalmetabolism', 'li', 'due', 'poor', 'solubility', 'short', 'halflife', 'low', 'bioavailability', 'medical', 'use', 'limited', 'konrad', 'andnieman', 'human', 'que', 'bioavailability', 'low', 'absorption', 'varies', 'subject', 'receive', 'mgdie', 'costa', 'que', 'may', 'reduce', 'infection', 'li', 'hepatic', 'lipemicoxidative', 'damage', 'cui', 'zhang', 'et', 'antioxidant', 'risk', 'xu', 'addition', 'que', 'isknown', 'exert', 'modulate', 'action', 'immunity', 'galleggiante', 'regard', 'mechanism', 'action', 'cell', 'linesque', 'able', 'inhibit', 'production', 'tnf', 'macrophagestang', 'lung', 'cell', 'induced', 'bylipopolysaccharide', 'lps', 'geraets', 'tnfa', 'mrna', 'level', 'glial', 'cell', 'cause', 'decrease', 'neuronal', 'celldeath', 'induced', 'microglial', 'activation', 'li', 'mainlytable', 'resveratrol', 'clinical', 'trial', 'metabolic', 'disordersstatusstudy', 'titleconditionsinterventionphasenct', 'numbercompleted', 'effects', 'resveratrol', 'patients', 'typetype', 'diabetes', 'diabetesterminated', 'effect', 'administration', 'resveratrol', 'ontype', 'diabetes', 'mellitus', 'mg', 'maximum', 'dose', 'g', 'daily', 'mg', 'time', 'dailyphase', 'variability', 'individuals', 'type', 'diabetes', 'mellituscompleted', 'effect', 'resveratrol', 'agerelated', 'insulinresistance', 'humanscompleted', 'regulation', 'intestinal', 'hepaticlipoprotein', 'secretion', 'resveratroltype', 'diabetes', 'mellitus', 'insulinresistancedyslipidaemia', 'insulin', 'resistancecompleted', 'effects', 'dietary', 'antioxidants', 'preventhypercholesterolemia', 'healthycardiovascular', 'diseasehealthy', 'aging', 'functional', 'foodcompletedwith', 'resultscompleted', 'effects', 'resveratrol', 'intype', 'diabetic', 'patientscompletedwith', 'resultseffect', 'resveratrol', 'administration', 'onmetabolic', 'syndrome', 'insulin', 'sensitivity', 'andinsulin', 'secretioncompleted', 'resveratrol', 'treatment', 'nonalcoholic', 'fatty', 'liver', 'disease', 'insulinresistance', 'overweight', 'adolescentsglucose', 'intolerance', 'aortic', 'stiffness', 'vasodilationtype', 'diabetes', 'mellitus', 'insulin', 'resistance', 'disorders', 'ofbone', 'density', 'structuremetabolic', 'syndrome', 'xnafld', 'type', 'diabetes', 'metabolicsyndromecompleted', 'study', 'resveratrol', 'treatment', 'forfriedreich', 'ataxiafriedreich', 'ataxiacompleted', 'effect', 'banaba', 'lagerstroemia', 'speciosaon', 'metabolic', 'syndrome', 'insulin', 'secretionand', 'insulin', 'sensitivitymetabolic', 'syndrome', 'x', 'mg', 'twice', 'daily', 'daysphase', 'mg', 'week', 'follow', 'g', 'weekdietary', 'supplement', 'red', 'wine', 'monthdietary', 'supplementresveratrol', 'monthtransresveratrol', 'mg', 'hesperetin', 'mg', 'combination', 'month', 'mg', 'daily', 'month', 'mg', 'daily', 'mg', 'time', 'daily', 'beforemeals', 'total', 'dose', 'mg', 'daily', 'mg', 'twice', 'daily', 'total', 'dailydose', 'mg', 'day', 'g', 'daily', 'mg', 'twice', 'daily', 'week', 'g', 'daily', 'gtwice', 'daily', 'weeksbanaba', 'capsule', 'mg', 'time', 'daily', 'meal', 'daysphase', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorsin', 'immunity', 'que', 'act', 'leukocyte', 'targetsmany', 'intracellular', 'signal', 'kinase', 'phosphatase', 'well', 'asenzymes', 'membrane', 'protein', 'li', 'theimmunostimulating', 'effect', 'que', 'due', 'induction', 'theexpression', 'interferong', 'ifng', 'derive', 'andinhibition', 'derive', 'normal', 'peripheral', 'bloodmononuclear', 'cell', 'nair', 'addition', 'que', 'reduces', 'cellproliferation', 'block', 'tyrosine', 'phosphorylationof', 'muthian', 'bright', 'nabavi', 'que', 'inhibits', 'enzymescox', 'lipoxygenase', 'lee', 'min', 'savikin', 'inthe', 'raw', 'cell', 'line', 'que', 'also', 'show', 'counteract', 'lpsinduced', 'phosphorylation', 'complexformation', 'tolllike', 'receptor', 'endale', 'oxidative', 'stress', 'occurs', 'follow', 'imbalance', 'defence', 'mechanism', 'excessive', 'generation', 'freeradicals', 'involve', 'various', 'pathology', 'diabetesatherosclerosis', 'hypertension', 'neurodegenerative', 'cancer', 'oboh', 'que', 'apowerful', 'ros', 'scavenger', 'antioxidant', 'action', 'due', 'tothe', 'presence', 'two', 'pharmacophores', 'within', 'molecularstructure', 'confer', 'favorable', 'freeradical', 'elimination', 'costa', 'generally', 'que', 'reducesthe', 'effect', 'free', 'radical', 'transfer', 'hydrogen', 'atom', 'andstabilizing', 'radical', 'feature', 'structurefunctionrelationship', 'oboh', 'que', 'also', 'act', 'antioxidant', 'prooxidant', 'agentat', 'low', 'concentration', '\\u00b5m', 'que', 'displayed', 'protective', 'effectagainst', 'oxidative', 'dna', 'damage', 'vitro', 'human', 'lymphocyte', 'li', 'concentration', '\\u00b5m', '\\u00b5m', 'que', 'wasable', 'directly', 'eliminate', 'ros', 'vitro', 'costa', 'howeverits', 'effect', 'vivo', 'likely', 'direct', 'due', 'ability', 'tomodulate', 'antioxidant', 'defense', 'mechanism', 'moderateoxidative', 'stress', 'fact', 'increase', 'antioxidant', 'defensesresulting', 'general', 'cytoprotection', 'halliwell', 'recentresearch', 'show', 'oxidize', 'ldl', 'oxldl', 'induces', 'oxidativestress', 'laraguzman', 'oxidative', 'injury', 'promote', 'rosgeneration', 'human', 'endothelial', 'cell', 'regulatesendothelial', 'function', 'therefore', 'enhancement', 'activityand', 'axis', 'upregulation', 'inhibits', 'oxidative', 'injuryinducing', 'endothelial', 'dysfunction', 'chen', 'shentu', 'que', 'may', 'reduce', 'oxldlinduced', 'oxidative', 'damageby', 'upregulating', 'ampk', 'hung', 'thereforepotentially', 'prevent', 'oxldlimpaired', 'inhibition', 'link', 'toendothelial', 'dysfunction', 'indicate', 'canfunction', 'regulator', 'improve', 'ampk', 'activity', 'oxldlstimulation', 'hung', 'recently', 'show', 'que', 'mgkg', 'reduceinsulin', 'resistance', 'improve', 'glucose', 'metabolism', 'reducingsensitivity', 'resistance', 'obob', 'mouse', 'via', 'hu', 'context', 'another', 'study', 'showedthat', 'streptozotocininduced', 'diabetic', 'rat', 'que', 'mgkginhibits', 'oxidative', 'damage', 'increase', 'expression', 'anddecreasing', 'level', 'nfkb', 'substrate', 'iskender', 'recent', 'year', 'community', 'focus', 'therole', 'apoptosis', 'cardiovascular', 'disease', 'show', 'thatoxidative', 'stress', 'myocardial', 'ischemia', 'hypoxia', 'ischemiareperfusion', 'injury', 'may', 'induce', 'myocardial', 'apoptosis', 'donniacuo', 'tang', 'colleague', 'evaluate', 'effect', 'que', 'inimproving', 'myocardialischemiareperfusion', 'injury', 'mirinduced', 'cell', 'apoptosis', 'vitro', 'vivo', 'expression', 'level', 'decrease', 'rat', 'mir', 'group', 'butwere', 'increase', 'treatment', 'que', 'tang', 'furthermore', 'activation', 'pathwayupregulated', 'expression', 'downregulated', 'bax', 'exertingantiapoptotic', 'effect', 'author', 'hypothesize', 'que', 'mightimprove', 'mirinduced', 'myocardial', 'damage', 'via', 'regulation', 'pathway', 'tang', 'que', 'also', 'report', 'regulate', 'ros', 'generation', 'mitigatemitochondrial', 'dysfunction', 'promote', 'study', 'develop', 'therapeutic', 'strategy', 'forosteoarthritis', 'que', 'show', 'increase', 'expression', 'level', 'tfam', 'phosphoampka', 'osteoarthritis', 'rat', 'hypothesis', 'quemight', 'act', 'via', 'signal', 'pathway', 'qiu', 'overall', 'suggest', 'que', 'may', 'counteractcardiovascular', 'disease', 'oxidative', 'damagethe', 'grow', 'body', 'evidence', 'support', 'effect', 'ofque', 'lead', 'clinical', 'use', 'demonstrate', 'number', 'ofclinical', 'trial', 'study', 'clinicaltrialsgov', 'list', 'completedstudies', 'use', 'que', 'different', 'metabolic', 'report', 'table', 'phase', 'clinicaltrial', 'measure', 'effect', 'que', 'glucosetolerance', 'postprandial', 'endothelial', 'function', 'subject', 'compare', 'effect', 'alphaglusidase', 'inhibitor', 'acarbosethe', 'administration', 'g', 'que', 'lead', 'decrease', 'postprandialblood', 'glucose', 'given', 'antioxidative', 'capacity', 'consider', 'goodcandidate', 'antioxidant', 'therapy', 'mucositis', 'c', 'idiopathic', 'pulmonary', 'osteoporosis', 'uric', 'acidmetabolism', 'cytokine', 'release', 'chronic', 'obstructive', 'pulmonary', 'disease', 'inthe', 'latter', 'study', 'que', 'supplementation', 'safely', 'tolerate', 'bypatients', 'mildtosevere', 'chronic', 'obstructive', 'pulmonarydisease', 'opening', 'way', 'towards', 'potential', 'use', 'que', 'atherapeutic', 'agent', 'conditionhowever', 'rsv', 'nutraceuticals', 'general', 'resultsof', 'molecular', 'study', 'que', 'obtain', 'vitro', 'investigationsand', 'animal', 'model', 'often', 'inconsistent', 'data', 'clinicaltrials', 'concentration', 'factor', 'dose', 'timing', 'administrationand', 'bioavailability', 'two', 'main', 'issue', 'require', 'additional', 'study', 'need', 'identify', 'theoptimal', 'concentration', 'que', 'exert', 'effectfor', 'example', 'insulin', 'sensitivityberberineberberine', 'bbr', 'isoquinoline', 'alkaloid', 'report', 'haveanalgesic', 'anticancer', 'myocardialprotective', 'property', 'cicero', 'baggioni', 'foundfrontiers', 'pharmacology', 'wwwfrontiersinaugust', 'volume', 'et', 'alnatural', 'activatorstable', 'quercetin', 'clinical', 'trial', 'metabolic', 'disordersstatusstudy', 'titleconditionsinterventionphasenct', 'numbercompleted', 'effect', 'quercetin', 'prevention', 'andtreatment', 'oral', 'effects', 'quercetin', 'chronicobstructive', 'pulmonary', 'disease', 'copdcompletedwith', 'resultscompleted', 'qtrial', 'patients', 'hepatitis', 'ccompleted', 'effects', 'quercetin', 'blood', 'sugar', 'andchemotherapy', 'induced', 'oralmucositischronic', 'obstructivepulmonary', 'diseasechronic', 'hepatitis', 'cdiabetes', 'mellitus', 'type', 'mg', 'daily', 'weeksphase', 'mg', 'daily', 'weekphase', 'day', 'mg', 'oral', 'single', 'dose', 'mgphase', 'phase', 'vessel', 'function', 'type', 'diabetescompleted', 'effect', 'quercetin', 'supplements', 'oncompletedhealthy', 'males', 'randomizedcrossover', 'trialtargeting', 'cells', 'inidiopathic', 'pulmonary', 'fibrosis', 'humantrialcompleted', 'provex', 'cv', 'supplement', 'toreduce', 'cytokines', 'andblood', 'pressurehyperuricemia', 'gout', 'kidneycalculi', 'diabetescardiovascular', 'diseaseidiopathic', 'pulmonary', 'fibrosisipfblood', 'pressure', 'mg', 'tablet', 'day', 'meal', 'breakfastpreferredearly', 'dos', 'administer', 'consecutive', 'day', 'consecutive', 'week', 'oral', 'administration', 'ofquercetin', 'mg', 'daily', 'mg', 'provex', 'cv', 'supplement', 'mouth', 'perday', 'weeksphase', 'effects', 'hesperidin', 'bone', 'mineralosteoporosis', 'osteopeniaphase', 'bone', 'metabolism', 'ofpostmenopausal', 'womento', 'exert', 'protective', 'antioxidative', 'effect', 'different', 'physiologicand', 'pathologic', 'condition', 'huang', 'li', 'mechanism', 'underlie', 'effect', 'remainunclear', 'bbr', 'described', 'potential', 'antitumor', 'agent', 'thatinduces', 'cell', 'cycle', 'arrest', 'phase', 'increase', 'protein', 'expression', 'decrease', 'expression', 'cyclin', 'de', 'cyclindependent', 'kinase', 'promote', 'apoptosis', 'human', 'leukemia', 'cellsli', 'bbr', 'also', 'deregulate', 'telomerase', 'activityand', 'promote', 'mitochondriadependent', 'apoptosis', 'hepatocarcinoma', 'cell', 'caspase', 'caspase', 'activation', 'parp', 'cleavage', 'induction', 'increase', 'expression', 'ofthe', 'proapoptotic', 'protein', 'bax', 'activation', 'foxotranscription', 'factor', 'inhibition', 'bclx', 'antiapoptotic', 'protein', 'expression', 'hwang', 'bbr', 'wasobserved', 'exert', 'apoptotic', 'effect', 'induce', 'rosproduction', 'increase', 'mapk', 'jnk', 'activity', 'human', 'colon', 'carcinoma', 'cell', 'increase', 'ca', 'andcytochrome', 'c', 'release', 'squamous', 'cell', 'song', 'addition', 'bbr', 'inhibits', 'proliferation', 'cancer', 'cellsthrough', 'pathway', 'oral', 'carcinoma', 'celllines', 'cell', 'bbr', 'inhibits', 'expression', 'bond', 'decrease', 'prostaglandin', 'production', 'andsuppresses', 'nfkb', 'ikk', 'erk', 'jnk', 'activity', 'furthermorebbr', 'inhibit', 'colon', 'cancer', 'cell', 'growth', 'activate', 'retinoid', 'xreceptor', 'rxra', 'bind', 'rxra', 'promote', 'bcatenin', 'degradation', 'ruan', 'however', 'studieshighlighted', 'potential', 'ability', 'bbr', 'prevent', 'oxidativestressinduced', 'senescence', 'activate', 'ampk', 'restoringnad', 'level', 'song', 'initial', 'research', 'reveal', 'role', 'signalingin', 'mediate', 'antioxidant', 'effect', 'bbr', 'diabetes', 'pang', 'lipid', 'metabolism', 'hasanein', 'thelipidlowering', 'activity', 'mediate', 'cotreatment', 'bbr', 'andrsv', 'investigate', 'mouse', 'expose', 'high', 'fat', 'diet', 'zhu', 'vivo', 'data', 'show', 'bbr', 'combine', 'rsvlowered', 'total', 'cholesterol', 'triglyceride', 'ldl', 'cholesterol', 'levelsin', 'mouse', 'also', 'vitro', 'treat', 'bbr', 'rsv', 'alone', 'bbr', 'andrsv', 'cotreatment', 'able', 'reduce', 'lipid', 'accumulation', 'morerobustly', 'single', 'treatment', 'bbr', 'combination', 'rsvdisplayed', 'hypolipidemic', 'effect', 'likely', 'mediate', 'regulation', 'moreover', 'bbr', 'pretreatment', 'seem', 'tocounteract', 'downregulation', 'zhu', 'antioxidant', 'effect', 'bbr', 'werealso', 'investigate', 'heart', 'yu', 'bbrmediated', 'reduce', 'mir', 'injury', 'affect', 'oxidative', 'damageand', 'signal', 'bbr', 'exert', 'anantioxidant', 'effect', 'decrease', 'generation', 'cardiacsuperoxide', 'expression', 'increase', 'sodlevels', 'yu', 'previous', 'study', 'also', 'show', 'activation', 'promotes', 'antioxidant', 'molecule', 'production', 'anddecreases', 'proapoptotic', 'protein', 'activationthus', 'protect', 'mir', 'lesion', 'hsu', 'well', 'activate', 'bbr', 'also', 'able', 'acetylation', 'trigger', 'antiapoptotic', 'signal', 'pathwaysvia', 'expression', 'bax', 'downregulation', 'yu', 'recent', 'report', 'described', 'protective', 'effect', 'bbragainst', 'doxorubicininduced', 'cardiovascular', 'damage', 'wu', 'effect']\",\n          \"['oral', 'administration', 'common', 'way', 'deliver', 'drug', 'systemic', 'circulation', 'targetans', 'orally', 'administer', 'drug', 'absorbed', 'intestine', 'metabolize', 'intestine', 'liver', 'theearly', 'stage', 'drug', 'development', 'important', 'predict', 'firstpass', 'metabolism', 'accurately', 'select', 'candidatedrugs', 'high', 'bioavailability', 'cell', 'line', 'derive', 'colorectal', 'cancer', 'widely', 'use', 'intestinalmodel', 'assess', 'drug', 'membrane', 'permeability', 'however', 'expression', 'major', 'drugmetabolizingenzymes', 'cytochrome', 'cyp', 'extremely', 'low', 'cell', 'difficult', 'predict', 'intestinalmetabolism', 'significant', 'factor', 'predict', 'oral', 'drug', 'bioavailability', 'previously', 'construct', 'mouseartificial', 'chromosome', 'vector', 'carry', 'cyp', 'oxidoreductasepor', 'gene', 'increase', 'cyp', 'expression', 'metabolic', 'activity', 'cell', 'via', 'transfer', 'thisvectorresults', 'current', 'study', 'improve', 'cell', 'assay', 'model', 'take', 'metabolism', 'account', 'weattempted', 'increase', 'cyp', 'expression', 'transfer', 'cell', 'cell', 'carryingthe', 'show', 'high', 'cyp', 'mrna', 'expression', 'activity', 'addition', 'high', 'metabolic', 'activity', 'availabilityfor', 'permeation', 'test', 'potential', 'assess', 'interaction', 'confirmeds', 'establish', 'cell', 'expect', 'enable', 'accurate', 'prediction', 'ofthe', 'absorption', 'metabolism', 'human', 'intestine', 'parental', 'cell', 'mammalian', 'artificialchromosome', 'vector', 'system', 'would', 'provide', 'useful', 'model', 'drug', 'developmentkeywords', 'mammalian', 'artificial', 'chromosome', 'chromosome', 'transfer', 'cytochrome', 'intestinal', 'cell', 'correspondence', 'genome', 'cellular', 'function', 'department', 'molecular', 'andcellular', 'biology', 'school', 'life', 'science', 'faculty', 'medicine', 'tottoriuniversity', 'nishicho', 'yonago', 'tottori', 'engineering', 'research', 'center', 'cerc', 'tottori', 'university', 'nishicho', 'yonago', 'tottori', 'japanfull', 'list', 'author', 'information', 'available', 'end', 'author', 'open', 'access', 'license', 'creative', 'common', 'attribution', 'international', 'licensewhich', 'permit', 'use', 'share', 'adaptation', 'distribution', 'reproduction', 'medium', 'format', 'long', 'giveappropriate', 'credit', 'original', 'author', 'source', 'provide', 'link', 'creative', 'common', 'licence', 'indicate', 'ifchanges', 'make', 'image', 'third', 'party', 'material', 'include', 'creative', 'commonslicence', 'unless', 'indicate', 'otherwise', 'credit', 'line', 'material', 'material', 'include', 'creative', 'commonslicence', 'intend', 'use', 'permit', 'statutory', 'regulation', 'exceeds', 'permit', 'use', 'need', 'obtainpermission', 'directly', 'copyright', 'holder', 'view', 'copy', 'licence', 'visit', 'creative', 'common', 'public', 'domain', 'dedication', 'waiver', 'applies', 'thedata', 'make', 'available', 'unless', 'otherwise', 'state', 'credit', 'line', 'data', 'bmc', 'biotechnology', 'page', 'bioavailability', 'important', 'area', 'concern', 'drugdevelopment', 'poor', 'oral', 'bioavailability', 'lead', 'drugwithdrawal', 'oral', 'drug', 'bioavailability', 'often', 'limited', 'bymetabolizing', 'enzyme', 'efflux', 'transporter', 'gut', 'cell', 'line', 'derive', 'human', 'colon', 'carcinoma', 'commonly', 'use', 'model', 'estimate', 'intestinal', 'absorption', 'new', 'drug', 'candidate', 'cell', 'express', 'variety', 'efflux', 'uptake', 'transporter', 'absence', 'low', 'level', 'cytochrome', 'cyp', 'isoforms', 'typically', 'express', 'human', 'intestinal', 'epithelium', 'therefore', 'cell', 'limited', 'use', 'evaluate', 'role', 'metabolism', 'inintestinal', 'absorption', 'oral', 'administration', 'predict', 'intestinal', 'absorption', 'drug', 'accurately', 'itis', 'necessary', 'modify', 'cell', 'increase', 'expression', 'cyp', 'isoformssome', 'study', 'report', 'metabolism', 'cell', 'enhance', 'transfection', 'withboth', 'cyp', 'oxidoreductase', 'por', 'essentially', 'described', 'previously', 'chromosomal', 'dna', 'counterstained', 'use', 'dapi', 'sigmaaldrich', 'st', 'louis', 'mo', 'usaimages', 'capture', 'use', 'fluorescencemicroscope', 'carl', 'zeiss', 'germany', 'bmc', 'biotechnology', 'page', 'rtqpcrwe', 'extract', 'mrna', 'use', 'rneasy', 'mini', 'kit', 'qiagen', 'germany', 'synthesize', 'firststrand', 'cdna', 'usingthe', 'high', 'capacity', 'cdna', 'reverse', 'transcription', 'kit', 'apply', 'biosystems', 'foster', 'city', 'ca', 'usa', 'primersare', 'list', 'additional', 'file', 'table', 'rtqpcranalysis', 'tb', 'green', 'premix', 'ex', 'taq', 'takara', 'usedand', 'relative', 'mrna', 'expression', 'evaluate', 'throughthe', 'method', 'gapdh', 'use', 'normalizationculture', 'timedependent', 'expression', 'level', 'change', 'cell', 'seededin', 'dish', 'concentration', 'cellswell', 'cell', 'lysed', 'use', 'trizol', 'invitrogen', 'causa', 'day', 'seed', 'rnawas', 'extract', 'purify', 'use', 'rneasy', 'mini', 'kitqiagen', 'thereafter', 'cdna', 'synthesis', 'performedusing', 'highcapacity', 'cdna', 'reverse', 'transcriptionkit', 'apply', 'biosystemsactivity', 'test', 'four', 'cypswe', 'test', 'metabolic', 'activity', 'ofthe', 'four', 'cypsusing', 'assay', 'promega', 'madison', 'wiusa', 'luminogenic', 'substrate', 'use', 'testwere', 'luciferinipa', 'luciferinme', 'luciferinh', 'luciferinhege', 'cell', 'wereseeded', 'plate', 'corn', 'density', 'cellswell', 'h', 'medium', 'changedand', 'h', 'later', 'add', 'transport', 'medium', 'tm', 'contain', 'substrate', 'tm', 'prepared', 'use', 'balance', 'salt', 'solution', 'hbss', 'mm', 'mm', 'glucose', 'mm', 'hepes', 'adjust', 'ph', 'incubation', 'add', 'detectionreagent', 'measure', 'luminescence', 'use', 'require', 'h', 'incubation', 'require', 'h', 'measurementthe', 'cell', 'wash', 'pb', 'dissolve', 'lysisbuffer', 'dilute', 'fivefold', 'amount', 'celltiter', 'glo', 'promega', 'add', 'lysateand', 'luminescence', 'measurement', 'perform', 'tonormalize', 'data', 'number', 'viable', 'cellswako', 'platereadermidazolam', 'mdz', 'permeability', 'testthe', 'obtain', 'clone', 'assess', 'mdz', 'permeation', 'test', 'cell', 'seed', 'cell', 'cultureinsert', 'plate', 'millipore', 'billerica', 'usa', 'concentration', 'cellswell', 'medium', 'changedonce', 'week', 'seed', 'every', 'secondweek', 'transepithelial', 'electrical', 'resistance', 'teer', 'wasmeasured', 'use', 'millicellers', 'millipore', 'mediumexchange', 'test', 'perform', 'seedingfor', 'test', 'tm', 'ph', 'prepared', 'add', 'mm', 'glucose', 'mm', 'hepes', 'tohbss', 'ph', 'use', 'donor', 'side', 'solutionwas', 'prepared', 'dissolve', 'mdz', 'tm', 'ph', 'acceptor', 'side', 'solution', 'prepared', 'add', 'fbs', 'tm', 'ph', 'test', 'day', 'themedium', 'remove', 'culture', 'insert', 'seededwith', 'cell', 'cell', 'rinse', 'twice', 'withtm', 'ph', 'tm', 'ph', 'tm', 'ph', 'wereadded', 'apical', 'basal', 'chamber', 'respectivelyand', 'cell', 'incubate', 'min', 'testwas', 'start', 'add', 'donor', 'side', 'solution', 'thedonor', 'side', 'chamber', 'acceptor', 'side', 'solution', 'tothe', 'acceptor', 'side', 'chamber', 'thirty', 'minute', 'thestart', 'test', 'solution', 'donor', 'side', 'andacceptor', 'side', 'chamber', 'collect', 'moreover', 'tomeasure', 'amount', 'mdz', 'mdz', 'cell', 'test', 'cultureinsert', 'quickly', 'rinse', 'three', 'time', 'icecoldtm', 'ph', 'membrane', 'cut', 'use', 'cutterand', 'icecold', 'tm', 'ph', 'add', 'cellswere', 'detach', 'membrane', 'sonicationand', 'cell', 'suspension', 'use', 'sample', 'thesesamples', 'deproteinized', 'store', 'measurementlcmsms', 'use', 'measurement', 'mdzand', 'mdz', 'sample', 'sciexframingham', 'usa', 'prominence', 'uflc', 'system', 'shimadzu', 'kyoto', 'japan', 'combine', 'measurement', 'hplc', 'condition', 'msms', 'conditionsare', 'show', 'additional', 'file', 'table', 'quantitativeanalysis', 'perform', 'multiple', 'reaction', 'monitoringmode', 'mass', 'transition', 'mz', 'formdz', 'mdz', 'mdz', 'data', 'analyze', 'usinganalyst', 'software', 'sciexequation', 'formula', 'calculate', 'extraction', 'ratio', 'erer', 'pmetabolite', 'chemicalinhibition', 'testketoconazoleindustry', 'tokyojapan', 'use', 'inhibitor', 'andchanges', 'metabolic', 'activity', 'measure', 'use', 'assay', 'luciferinipa', 'cell', 'seededin', 'collagencoated', 'plate', 'cellswell', 'medium', 'change', 'thenext', 'daythe', 'medium', 'collect', 'cell', 'werewashed', 'twice', 'pb', 'tm', 'ph', 'contain', 'ketoconazole', 'tokyo', 'chemical', 'industry', 'add', 'toeach', 'set', 'three', 'well', 'tm', 'adjust', 'ph', 'byadding', 'mm', 'mm', 'glucose', 'mm', 'bmc', 'biotechnology', 'page', 'receive', 'april', 'accepted', 'august', 'referencesbenet', 'l', 'wu', 'c', 'hebert', 'wacher', 'v', 'intestinal', 'drug', 'metabolism', 'andantitransport', 'process', 'potential', 'paradigm', 'shift', 'oral', 'drug', 'delivery', 'jcontrol', 'release', 'f', 'ding', 'x', 'zhang', 'qy', 'update', 'role', 'intestinal', 'enzyme', 'drug', 'disposition', 'acta', 'pharm', 'sin', 'b', 'kazuki', 'k', 'harada', 'n', 'kuze', 'j', 'chiba', 'iwao', 'matsunaga', 'abes', 'oshimura', 'kazuki', 'development', 'cell', 'nadphcytochrome', 'reductase', 'use', 'human', 'artificialchromosome', 'prediction', 'intestinal', 'extraction', 'ratio', 'drug', 'metab', 'pharmacokinet', 'li', 'davitt', 'cm', 'huang', 'sm', 'thummel', 'k', 'penman', 'bw', 'crespi', 'cltransport', 'metabolic', 'characterization', 'cell', 'express', 'plus', 'oxidoreductase', 'pharm', 'p', 'thummel', 'ke', 'fisher', 'jm', 'paine', 'mf', 'lown', 'k', 'watkins', 'pbexpression', 'enzymatically', 'active', 'cell', 'grown', 'onextracellular', 'matrixcoated', 'permeable', 'support', 'presence', 'mol', 'pharmacol', 'j', 'liu', 'du', 'morrison', 'j', 'shipman', 'r', 'pang', 'k', 'upregulation', 'oftransporters', 'enzyme', 'vitamin', 'receptor', 'ligand', 'vitamin', 'analog', 'cell', 'monolayer', 'jpharmacol', 'exp', 'ther', 'cl', 'mangravite', 'lm', 'benet', 'lz', 'characterize', 'expression', 'efflux', 'transporter', 'pgp', 'cell', 'induction', 'sodium', 'butyrate', 'thephorbol', 'ester', 'pharm', 'honkakoski', 'p', 'toppinen', 'mr', 'niva', 'reinisalo', 'palmgren', 'jjmonkkonen', 'j', 'absorption', 'property', 'pglycoprotein', 'activity', 'cell', 'line', 'eur', 'j', 'pharm', 'sci', 'monkkonen', 'j', 'uusitalo', 'j', 'turpeinen', 'pelkonen', 'honkakoskip', 'metabolic', 'efflux', 'property', 'cell', 'stably', 'transfected', 'withnuclear', 'receptor', 'pharm', 'j', 'hakkarainen', 'jj', 'petsalo', 'vellonen', 'k', 'tolonen', 'reponen', 'pforsberg', 'mm', 'honkakoski', 'p', 'genetically', 'modify', 'cell', 'withimproved', 'cytochrome', 'metabolic', 'capacity', 'j', 'pharm', 'sci', 'hbss', 'cell', 'preincubated', 'h', 'dilute', 'substrate', 'wasadded', 'one', 'hour', 'later', 'supernatant', 'wascollected', 'well', 'mixed', 'detectionreagent', 'luminescence', 'value', 'measuredusing', 'infinite', 'plate', 'reader', 'wakosupplementary', 'informationsupplementary', 'information', 'accompanies', 'paper', 'file', 'figure', 'comparison', 'gene', 'expression', 'betweenhuman', 'small', 'intestine', 'day', 'culture', 'table', 'primer', 'sequence', 'genomic', 'pcr', 'rtqpcrtable', 'lcmsms', 'analysis', 'condition', 'mdz', 'mdzabbreviationscyp', 'cytochrome', 'ac', 'artificial', 'chromosome', 'mmct', 'microcellmediated', 'chromosome', 'transfer', 'por', 'oxidoreductase', 'hac', 'humanartificial', 'chromosome', 'mac', 'mouse', 'artificial', 'chromosome', 'ddi', 'cho', 'chinese', 'hamster', 'ovary', 'mdz', 'midazolamteer', 'transepithelial', 'electrical', 'resistance', 'er', 'extraction', 'ratioacknowledgmentswe', 'thank', 'satoru', 'iwado', 'tottori', 'university', 'technical', 'assistance', 'theexperiments', 'also', 'thank', 'dr', 'hiroyuki', 'kugoh', 'dr', 'masaharu', 'hiratsuka', 'drhiroyuki', 'satofuka', 'dr', 'takahito', 'ohira', 'tottori', 'university', 'criticaldiscussions', 'research', 'partly', 'perform', 'tottori', 'bio', 'frontiermanaged', 'tottori', 'prefecture', 'thank', 'edanz', 'group', 'wwwedanzeditingcomac', 'edit', 'draft', 'contributionsall', 'author', 'conceive', 'design', 'experiment', 'yo', 'kka', 'performedthe', 'experiment', 'yo', 'sa', 'kko', 'yk', 'write', 'paper', 'mo', 'yksupervised', 'study', 'author', 'read', 'approve', 'final', 'manuscriptfundingthis', 'work', 'support', 'part', 'basis', 'support', 'innovative', 'drugdiscovery', 'life', 'science', 'research', 'bind', 'japan', 'agency', 'formedical', 'research', 'development', 'amed', 'grant', 'ykavailability', 'data', 'materialsthe', 'data', 'material', 'use', 'andor', 'analyze', 'current', 'study', 'areavailable', 'correspond', 'author', 'reasonable', 'requestethics', 'approval', 'consent', 'participatenot', 'applicableconsent', 'publicationnot', 'applicablecompeting', 'interestsdr', 'mitsuo', 'oshimura', 'ceo', 'shareholder', 'trans', 'chromosomics', 'incdr', 'satoshi', 'abe', 'member', 'trans', 'chromosomics', 'inc', 'otherauthors', 'declare', 'conflict', 'interestauthor', 'genome', 'cellular', 'function', 'department', 'molecular', 'andcellular', 'biology', 'school', 'life', 'science', 'faculty', 'medicine', 'tottoriuniversity', 'nishicho', 'yonago', 'tottori', 'japan', 'research', 'center', 'cerc', 'tottori', 'university', 'nishicho', 'yonagotottori', 'japan', 'chromosomics', 'inc', 'nishicho', 'yonagotottori', 'japan', 'biopharmaceutics', 'meijipharmaceutical', 'university', 'noshio', 'kiyose', 'tokyo', 'japan', 'oshimura', 'uno', 'n', 'kazuki', 'katoh', 'inoue', 'pathway', 'fromchromosome', 'transfer', 'engineering', 'result', 'human', 'mouseartificial', 'chromosome', 'variety', 'application', 'biomedicalchallenges', 'chromosom', 'abe', 'kobayashi', 'k', 'nakajima', 'oshimura', 'kazuki', 'human', 'andmouse', 'artificial', 'chromosome', 'technology', 'study', 'pharmacokineticsand', 'toxicokinetics', 'drug', 'metab', 'pharmacokinet', 'hoshiya', 'h', 'takiguchi', 'abe', 'iida', 'osaki', 'katoh', 'hiratsukam', 'shirayoshi', 'hiramatsu', 'k', 'ueno', 'e', 'kajitani', 'n', 'yoshino', 'kazuki', 'k', 'ishiharac', 'takehara', 'tsuji', 'ejima', 'f', 'toyoda', 'saka']\",\n          \"['recently', 'current', 'pandemic', 'coronavirus', 'disease', 'covid', 'characterize', 'pulmonary', 'infection', 'human', 'cause', 'novel', 'virus', 'strain', 'family', 'coronaviridae', 'know', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'previous', 'outbreak', 'severe', 'acute', 'respiratory', 'syndrome', 'sars', 'middle', 'east', 'respiratory', 'syndrome', 'mers', 'demonstrate', 'lethality', 'coronaviruses', 'cross', 'specie', 'barrier', 'infect', 'human', 'far', 'six', 'coronaviruses', 'infect', 'human', 'identify', 'novel', 'coronavirus', 'seventh', 'one', 'described', 'date', 'responsible', 'respiratory', 'infection', 'sarscov', 'merscov', 'new', 'belong', 'betacoronavirus', 'family', 'autophagy', 'lysosomedependent', 'degradative', 'pathway', 'chq', 'analogue', 'hcq', 'know', 'clinically', 'relevant', 'autophagy', 'inhibitor', 'chq', 'weak', 'base', 'inhibits', 'lysosomal', 'acidification', 'prevents', 'fusion', 'autophagosomes', 'lysosome', 'subsequent', 'autophagic', 'degradation', 'inhibition', 'autophagy', 'chq', 'stimulates', 'superoxide', 'generation', 'ubiquitinconjugated', 'protein', 'accumulation', 'apoptosis', 'colon', 'cancer', 'xenograft', 'model', 'chq', 'treatment', 'clearly', 'inhibit', 'autophagy', 'mouse', 'lung', 'efficiently', 'ameliorate', 'acute', 'lung', 'injury', 'dramatically', 'improve', 'survival', 'rate', 'mouse', 'infect', 'live', 'avian', 'influenza', 'virus', 'virusinduced', 'autophagic', 'cell', 'death', 'alveolar', 'epithelial', 'cell', 'pathway', 'involve', 'kinase', 'akt', 'tumor', 'suppressor', 'protein', 'mammalian', 'target', 'rapamycin', 'autophagyblocking', 'agent', 'might', 'useful', 'prophylactic', 'therapeutic', 'infection', 'human', 'virus', 'furthermore', 'prentice', 'suggest', 'authophagy', 'induced', 'coronavirus', 'mouse', 'hepatitis', 'virus', 'mhv', 'require', 'formation', 'double', 'membranebound', 'mhv', 'replication', 'complex', 'significantly', 'enhance', 'efficiency', 'replication', 'replication', 'virus', 'impaired', 'knockout', 'embryonic', 'stem', 'cell', 'author', 'also', 'examine', 'sarscovs', 'found', 'similar', 'colocalization', 'key', 'viral', 'replication', 'protein', 'endogenous', 'protein', 'marker', 'autophagosome', 'could', 'assume', 'autophagy', 'inhibitor', 'like', 'chq', 'could', 'inhibit', 'virus', 'replication', 'present', 'exact', 'role', 'autophagy', 'cov', 'infection', 'remains', 'debatable', 'much', 'evidence', 'suggest', 'endocytic', 'pathway', 'play', 'key', 'role', 'mediate', 'viral', 'entry', 'many', 'covs', 'include', 'sarscovs', 'merscovs', 'possibly', 'antiinflammatory', 'property', 'chqhcq', 'also', 'consider', 'several', 'study', 'suggest', 'multiple', 'failure', 'yet', 'identify', 'infect', 'patient', 'probably', 'multiple', 'pathway', 'could', 'involve', 'fig', 'conclusion', 'cause', 'coronavirus', 'disease', 'declare', 'global', 'pandemic', 'world', 'health', 'anization', 'despite', 'clinical', 'characteristic', 'differentiate', 'sarscov', 'merscov', 'seasonal', 'influenza', 'pathogen', 'phylogenetic', 'similarity', 'sarscov', 'mers', 'cov', 'encode', 'protein', 'exhibit', 'high', 'sequence', 'identity', 'related', 'batderived', 'coronaviruses', 'notable', 'difference', 'longer', 'spike', 'protein', 'encode', 'compare', 'bat', 'sarslike', 'coronaviruses', 'sarscov', 'merscov', 'addition', 'distinct', 'sarscov', 'phylogeny', 'complete', 'rnadependent', 'rna', 'polymerase', 'rdrp', 'gene', 'moreover', 'receptorbinding', 'domain', 'directly', 'engages', 'receptor', 'cell', 'entry', 'closely', 'related', 'sarscovs', 'amino', 'acid', 'identity', 'since', 'outbreak', 'researcher', 'release', 'many', 'agent', 'could', 'potential', 'efficacy', 'currently', 'clinically', 'proven', 'specific', 'antiviral', 'agent', 'available', 'infection', 'like', 'sarscov', 'merscov', 'certain', 'agent', 'like', 'chloroquine', 'hydroxychloroquine', 'lopinavirritonavir', 'remdesivir', 'use', 'ongoing', 'clinical', 'trial', 'world', 'hope', 'far', 'delineate', 'role', 'treatment', 'prophylaxis', 'furthermore', 'due', 'availability', 'use', 'decade', 'proven', 'safety', 'record', 'reasonable', 'suggest', 'may', 'appropriate', 'treatment', 'remdesivir', 'adenosine', 'analogue', 'wellstudied', 'mechanism', 'action', 'cov', 'infection', 'target', 'rnadependent', 'rna', 'polymerase', 'block', 'viral', 'rna', 'synthesis', 'promising', 'antiviral', 'drug', 'antiviral', 'study', 'cell', 'culture', 'animal', 'model', 'available', 'human', 'safety', 'data', 'well', 'clear', 'mechanism', 'action', 'characterize', 'rdv', 'directacting', 'antiviral', 'since', 'author', 'found', 'treatment', 'significantly', 'accelerate', 'clinical', 'improvement', 'hence', 'antiviral', 'effect', 'inhibitor', 'sarscov', 'main', 'protease', 'far', 'investigate', 'although', 'chq', 'hcq', 'wellknown', 'drug', 'treatment', 'k', 'uzunova', 'observe', 'fatal', 'case', 'likely', 'associate', 'direct', 'viral', 'infection', 'destruction', 'susceptible', 'cell', 'eg', 'endothelial', 'cell', 'also', 'effect', 'proinflammatory', 'cytokine', 'chemokines', 'mediator', 'release', 'infect', 'activate', 'cell', 'monocyte', 'macrophage', 'clinical', 'worsen', 'individual', 'sars', 'week', 'apparently', 'unrelated', 'uncontrolled', 'sars', 'coronavirus', 'replication', 'may', 'related', 'immunopathological', 'damage', 'another', 'study', 'reveals', 'presence', 'viral', 'element', 'within', 'endothelial', 'cell', 'accumulation', 'inflammatory', 'cell', 'lead', 'endotheliitis', 'several', 'direct', 'consequence', 'viral', 'involvement', 'host', 'inflammatory', 'response', 'moreover', 'chq', 'immunomodulatory', 'effect', 'suppress', 'productionrelease', 'tumour', 'necrosis', 'mediate', 'inflammatory', 'complication', 'several', 'viral', 'disease', 'chloroquinehcq', 'report', 'inhibit', 'production', 'soluble', 'mature', 'tnf', 'macrophage', 'cell', 'line', 'inhibit', 'receptor', 'human', 'histocytic', 'cell', 'inhibit', 'peripheral', 'blood', 'mononuclear', 'cell', 'pbmc', 'reduce', 'production', 'lipopolysaccharide', 'lpsinduced', 'release', 'human', 'monocytic', 'cell', 'suggest', 'chq', 'exerts', 'antiinflammatory', 'immunomodulatory', 'effect', 'predominantly', 'pretranslational', 'nonlysosomotropic', 'mechanism', 'chloroquineinduced', 'inhibition', 'tnf', 'production', 'mediate', 'lysosomotropic', 'mechanism', 'chloroquine', 'probably', 'act', 'tnf', 'secretion', 'disrupt', 'iron', 'homeostasis', 'besides', 'antiviral', 'activity', 'due', 'suppressive', 'effect', 'productionrelease', 'interleukin', 'chqhcq', 'may', 'effectively', 'use', 'treatment', 'viral', 'infection', 'characterize', 'symptom', 'associate', 'inflammatory', 'process', 'andor', 'immunehyperactivation', 'antiinflammatory', 'effect', 'chq', 'remain', 'poorly', 'understood', 'regulation', 'proinflammatory', 'cytokine', 'chq', 'also', 'act', 'immune', 'system', 'cell', 'signal', 'chq', 'inhibits', 'activation', 'mapk', 'cell', 'evokes', 'activation', 'erk', 'independently', 'infection', 'result', 'suggest', 'chq', 'may', 'inhibit', 'cov', 'replication', 'suppress', 'activation', 'additionally', 'chq', 'strongly', 'inhibit', 'phosphorylation', 'mitogenactivated', 'protein', 'kinase', 'mapk', 'lesser', 'extent', 'cjun', 'nterminal', 'kinase', 'extracellular', 'signalregulated', 'kinase', 'chloroquine', 'could', 'also', 'inhibit', 'innate', 'immune', 'response', 'trough', 'downregulation', 'signal', 'pathway', 'require', 'endocytosis', 'acidification', 'endosomes', 'within', 'plasmacytoid', 'dendritic', 'cell', 'pdcs', 'act', 'novel', 'antagonist', 'chemokine', 'receptor', 'suppress', 'pancreatic', 'cancer', 'cell', 'proliferation', 'hand', 'another', 'hypothesize', 'mechanism', 'chq', 'via', 'inhibition', 'antigen', 'degradation', 'improve', 'crosspresentation', 'efficiency', 'dc', 'vitro', 'vivo', 'evidence', 'suggest', 'short', 'course', 'treatment', 'chq', 'follow', 'booster', 'dose', 'soluble', 'antigen', 'immunization', 'efficiently', 'enhance', 'human', 'cell', 'response', 'single', 'vaccination', 'inactivate', 'influenza', 'virus', 'combine', 'chloroquine', 'treatment', 'elicits', 'high', 'cell', 'immunity', 'mouse', 'regulation', 'inflammasome', 'activation', 'may', 'offer', 'promising', 'therapeutic', 'approach', 'inhibit', 'slow', 'process', 'acute', 'respiratory', 'distress', 'syndrome', 'hcq', 'know', 'inhibitor', 'potential', 'clinical', 'effectiveness', 'certainly', 'base', 'downregulation', 'expression', 'major', 'proinflammatory', 'cytokine', 'elevate', 'plasma', 'hospitalize', 'patient', 'associate', 'signal', 'pathway', 'seem', 'drive', 'pathogenicity', 'secretion', 'primarily', 'initiate', 'inflamm']\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "y = df['label']"
      ],
      "metadata": {
        "id": "4cD77S4ntCDd"
      },
      "execution_count": 12,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_processed['processed_text'] = df_processed['processed_text'].apply(''.join)"
      ],
      "metadata": {
        "id": "aAPcxj9AtDQn"
      },
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "vectorizer = TfidfVectorizer()\n",
        "X = vectorizer.fit_transform(df_processed['processed_text'])"
      ],
      "metadata": {
        "id": "E_AYrXt5tElM"
      },
      "execution_count": 14,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "tfidf_transformer = TfidfTransformer()\n",
        "X_tfidf = tfidf_transformer.fit_transform(X)"
      ],
      "metadata": {
        "id": "WO2i7sYMtFSA"
      },
      "execution_count": 15,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sentences = [sentence.split() for sentence in df_processed['processed_text']]"
      ],
      "metadata": {
        "id": "9sqrbjMqtHa9"
      },
      "execution_count": 16,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "word_2_vec = gensim.models.Word2Vec(sentences=sentences, min_count=1, vector_size=100,\n",
        "                                window=5, sg=1)"
      ],
      "metadata": {
        "id": "i53o4wj2tIsM"
      },
      "execution_count": 17,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def sent_vec(sent):\n",
        "    vector_size = word_2_vec.vector_size\n",
        "    wv_res = np.zeros(vector_size)\n",
        "    ctr = 1\n",
        "\n",
        "    for w in sent:\n",
        "        if w in word_2_vec.wv:\n",
        "            ctr += 1\n",
        "            wv_res += word_2_vec.wv[w]\n",
        "\n",
        "    wv_res = wv_res / ctr\n",
        "    return wv_res"
      ],
      "metadata": {
        "id": "VQN69C3stJ8M"
      },
      "execution_count": 18,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def vectorize(sentence):\n",
        "    words = sentence.split()\n",
        "    words_vecs = [word_2_vec.wv[word] for word in words if word in word_2_vec.wv]\n",
        "    if len(words_vecs) == 0:\n",
        "        return np.zeros(100)\n",
        "    words_vecs = np.array(words_vecs)\n",
        "    return words_vecs.mean(axis=0)"
      ],
      "metadata": {
        "id": "K2qMKr7TtLZz"
      },
      "execution_count": 19,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "X_word2vec = np.array([vectorize(sentence) for sentence in df_processed['processed_text']])"
      ],
      "metadata": {
        "id": "OuDopIMxtMvW"
      },
      "execution_count": 20,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "ZRgHrvL3w_G-"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Entraînement et évaluation avec SVM sur TF-IDF\n",
        "X_train, X_test, y_train, y_test = train_test_split(X_tfidf, y, test_size=0.2, random_state=42)\n",
        "svm_model = SVC(kernel='linear')\n",
        "svm_model.fit(X_train, y_train)\n",
        "y_pred = svm_model.predict(X_test)\n",
        "print(\"\\nRapport de classification pour TF-IDF + SVM :\")\n",
        "print(classification_report(y_test, y_pred))\n",
        "print('Matrice de confusion')\n",
        "print(confusion_matrix(y_test, y_pred))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9ahumOoHtODl",
        "outputId": "bb609f42-c78c-46e6-ee68-798f44e8a7e9"
      },
      "execution_count": 21,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Rapport de classification pour TF-IDF + SVM :\n",
            "                precision    recall  f1-score   support\n",
            "\n",
            "  Colon_Cancer       0.93      0.97      0.95       517\n",
            "   Lung_Cancer       1.00      1.00      1.00       407\n",
            "Thyroid_Cancer       0.97      0.94      0.95       590\n",
            "\n",
            "      accuracy                           0.96      1514\n",
            "     macro avg       0.97      0.97      0.97      1514\n",
            "  weighted avg       0.96      0.96      0.96      1514\n",
            "\n",
            "Matrice de confusion\n",
            "[[499   0  18]\n",
            " [  0 407   0]\n",
            " [ 37   0 553]]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Entraînement et évaluation avec SVM sur Word2Vec\n",
        "X_train, X_test, y_train, y_test = train_test_split(X_word2vec, y, test_size=0.2, random_state=42)\n",
        "svm_model = SVC(kernel='linear')\n",
        "svm_model.fit(X_train, y_train)\n",
        "y_pred = svm_model.predict(X_test)\n",
        "print(\"\\nRapport de classification pour TF-IDF + SVM :\")\n",
        "print(classification_report(y_test, y_pred))\n",
        "print('Matrice de confusion')\n",
        "print(confusion_matrix(y_test, y_pred))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "EdqEZbWktPy6",
        "outputId": "d894aed6-e567-470f-8954-f1efff1c6511"
      },
      "execution_count": 22,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Rapport de classification pour TF-IDF + SVM :\n",
            "                precision    recall  f1-score   support\n",
            "\n",
            "  Colon_Cancer       0.66      0.65      0.66       517\n",
            "   Lung_Cancer       0.89      0.90      0.90       407\n",
            "Thyroid_Cancer       0.68      0.68      0.68       590\n",
            "\n",
            "      accuracy                           0.73      1514\n",
            "     macro avg       0.74      0.75      0.74      1514\n",
            "  weighted avg       0.73      0.73      0.73      1514\n",
            "\n",
            "Matrice de confusion\n",
            "[[338  13 166]\n",
            " [ 20 367  20]\n",
            " [156  33 401]]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "KalsDUsM2aPe"
      }
    }
  ]
}